View
21
Download
0
Category
Preview:
Citation preview
1
EFFECTS OF XANTHONE GLYCOSIDE FROM Peperomia pellucida (L.) Kunth
AGAINST HYPERGLYCEMIA AND ALTERATIONS IN PANCREAS OF HFD/STZ-
INDUCED DIABETIC MICE Mus musculus
DIANNE MAE B. TAN
JOLAINE ASHLEY T. VALLO
An Undergraduate Thesis
Submitted to the Department of Biology
College of Arts and Sciences
University of the Philippines Manila
Padre Faura, Manila
In partial fulfillment of the requirements
For the degree of
Bachelor of Science in Biology
May 2018
Department of Biology
i
ii
TABLE OF CONTENTS
TABLE OF CONTENTS………………………………..……………………………………......ii
LIST OF FIGURES………………………………..……………………………………….…......v
LIST OF TABLES………………………………..…………………………………….…….......vi
LIST OF APPENDICES………………………………..……………………………………......vii
ACKNOWLEDGEMENT………………………………..……………………………………..viii
ABSTRACT………………………………..…………………………………………………......1
INTRODUCTION………………………………..………………………………………….........2
Background of the Study..………………………………………….....….....…..…...........2
Statement of the Problem..…………………………………………...….....…....…..........4
Research Objectives..………………………………………………………….....….........4
Significance of the Study..……………………………………...….....………………......5
Scope and Limitations of the Study..………………………………………........…..........5
REVIEW OF RELATED LITERATURE………..…………………………………………........7
Morphology of Peperomia pellucida…..…………………………………………............7
Chemical Constituents of Peperomia pellucida…..………………………………............7
Xanthone Glycoside…..…………………………………………......................................8
Pharmacological Properties of Xanthone Glycoside…..……………………………..…..9
Diabetes Mellitus…..………………………………………….........................................10
Type II Diabetes Mellitus…..…………………………………………............................11
Gross Morphology and Histology of the Pancreas...………………………………...…..11
Histopathological Studies of Islets in Type II Diabetes Mellitus…..………………........13
HFD/STZ Mouse Model…..…………………………………………….....…….…........13
iii
MATERIALS AND METHODOLOGY…………………………………….....………..............15
Plant Extraction and Fractionation…………………………………….....…….…...........15
Purification of Xanthone Glycoside…………………………………….....…….….........15
Acclimatization of Mice…………………………………….....…….…..........................17
Induction of Diabetes…………………………………….....……….................…...........17
Experimental Set-up…………………………………….....…….…....….........................18
Obtaining Body Weight…………………………………….....…….….…......................19
Blood Glucose Analysis…………………………………….....…….…….......................19
Examination of Gross Morphology and Histopathology of Mice Pancreas…….….........19
Statistical Analysis…………………………………….....…….…...................................21
RESULTS…..…………………………………………….....…….…..........................................22
Body Weight…..…………………………………………….....…….…..........................22
Blood Glucose Levels…..…………………………………………….....…….…............24
Gross Morphology of Pancreas…..…………………………………….....…….…..........26
Islet Diameter…..…………………………………………….....……………............…..28
Histopathology of Pancreas…..……………………………………….....…….…...........29
DISCUSSION…..…………………………………………….....…….…....……….....………...33
Induction of Type 2 Diabetes…..……………………………………….....…….….........33
Effect on Body Weight…..…………………………………………….....…….…..........33
Effect on Blood Glucose Levels…..……………………………………….…….…........35
Pancreas Morphology, Histology and Islet Diameter…………………….……...............41
Group A: Negative Control (Standard Diet)……….…….…..….…..….…..........43
Group B: HFD + STZ + Metformin……….…….…....….…..….…..….……......43
iv
Group C: HFD + STZ + 10 mg/kg Xanthone Glycoside……….…….….............46
Group D: HFD + STZ + 20 mg/kg Xanthone Glycoside……….…….….............48
Group E: HFD + STZ + 40 mg/kg Xanthone Glycoside……….…….….............50
Group F: Positive Control (HFD + STZ)……….…….…….…..….…..…...........51
CONCLUSION……….…….…......….…….…......….…….…......….…….…............................53
RECOMMENDATION……….…….….....….…….…......….…….…......….…….....…............54
LITERATURE CITED……….…….….…….…......….…….…......….…….…..........…............55
APPENDICES……….…….…….…….…......….…….…......….…….…...................................69
BIOGRAPHICAL DATA……….……….…….…......….…….…......….…….….......…............77
v
LIST OF FIGURES
FIGURE PAGE
1 Mean body weights of all groups of male ICR Mus musculus from
the week after acclimatization and after STZ/HFD induction………………….23
2 Mean body weights of groups of male ICR Mus musculus from
the initial and final week of treatment with xanthone glycoside………….……23
3 Mean blood glucose levels of all groups of male ICR Mus musculus
before and after STZ induction………………………………………………….25
4 Mean blood glucose levels (mg/dL) of all groups of male ICR
Mus musculus before and after treatment of xanthone glycoside……………….25
5 Gross Morphology of the Pancreas……………………………………………...27
6 Mean diameters of the pancreatic Islets of Langerhans per male ICR
mice group…………………………………..…………………………………...28
7 Mean histological scores of pancreatic tissue samples from HFD/STZ-induced
hyperglycemic male ICR mice……………………………..…………………....29
8 Representative Micrographs of Hematoxylin and Eosin-Stained (H&E)
Pancreatic Islets of Mus musculus…………………………………………….....30
9 Representative Micrographs of Hematoxylin and Eosin-Stained (H&E)
Pancreatic Acinar Cells of Mus musculus……………………………………......31
vi
LIST OF TABLES
TABLE PAGE
1 Scoring system for histological alterations as indicators of damages in
the pancreatic acinar and islets of Langerhans of diabetic male ICR mice…......20
2 Summary of the histological alterations observed in pancreatic islets
treated with xanthone glycoside obtained from P. pellucida
methanolic extract.………….……………….……………….………………….32
vii
LIST OF APPENDICES
APPENDIX PAGE
A Letter of Approval for Implementation from the IACUC, NIH………………...69
B Certificate of Authentication from Institute of Biology, College of Science,
University of the Philippines Diliman…………………………………………..70
C Phytochemical Analysis Results of Butanol Fraction from P. pellucida
from NIH, UP Manila…………………………………………………………..71
D Computation for Total Xanthone Glycoside Needed…………………………...73
E Computation for Streptozotocin Amount………………….…………….……...73
F1 Paired T-Test Results Between Before and After HFD/STZ Induction
Body Weights……………….…………….…………….…………….………...73
F2 Paired T-Test Results Between Body Weights of Mouse Subjects
Before and After Treatment……….…………….…………….…………….….74
G1 Paired T-Test Results Between Blood Glucose Levels of Mouse Subjects
Before and After STZ Induction……….…………….…………….…………...74
G2 Paired T-Test Results Between Blood Glucose Levels of Mouse Subjects
Before and After Treatment……….…………….…………….……...………...74
H1 Kruskal-Wallis One-Way Analysis Results for Mean Histological
Index Scores……………….…………….…………….…………….…..……...75
H2 Mann-Whitney U Test Results for Mean Histological Index Scores...………....75
viii
ACKNOWLEDGEMENT
The researchers would like to express our deepest and wholehearted gratitude to the following:
Our thesis adviser, Prof. Kimberly S. Beltran-Benjamin, for her unwavering guidance,
patience and support, and for simply believing that we could successfully make it until the end;
Dr. Elisa L. Co and Dr. Thucydides L. Salunga for sharing their wonderful insights and
criticisms on our study;
Kuya Edgar and Kuya Max for all the encouragements and for cheering us up when things go
bad, and as well as for having patience when we borrow laboratory equipment;
Kuya Mel of UP-NIH for teaching and assisting us in mice handling during the duration of the
experiment;
Mang Mon of UP Diliman for helping us in collecting and authenticating our plant samples;
To our home for four years, the Department of Biology, for always pushing us to always strive
for excellence and for helping us prepare for our future careers;
To our fellow blockmates and friends who have been with us for four years for all the times we
keep each other sane and happy;
To our families who have been always there and constantly supporting us all throughout our
thesis.
Most of all, we thank our Almighty God for endlessly guiding us in all of our endeavors
especially in conducting this study.
1
ABSTRACT
Type II diabetes mellitus (T2DM) known to be the most prevalent form of diabetes, is
caused by defects in insulin secretion, decreased sensitivity of insulin target cells, and β-cell
dysfunction. This study tests the effects of xanthone glycoside from Peperomia pellucida on
blood glucose levels and pancreas histology of HFD/STZ- induced diabetic Mus musculus.
The experiment used 30 mice divided equally into 6 groups. Two groups served as the
negative and positive control, while the remaining 4 groups were administered with
metformin, 10 mg/kg xanthone glycoside, 20 mg/kg xanthone glycoside, and 40 mg/kg
xanthone glycoside. Body weight, blood glucose, islet diameter, and pancreas histology were
obtained and analyzed. Results indicate that 20 mg/kg xanthone glycoside from P. pellucida
significantly lowered blood glucose levels and can reduce alterations in pancreatic histology
of HFD/STZ induced diabetic Mus musculus.
2
INTRODUCTION
Background of the Study
According to the International Diabetes Federation (IDF) (2015), approximately 415
million adults have diabetes and by 2040 it will rise up to 642 million adults. About 90% of
the cases belong to Type II Diabetes because of unhealthy lifestyle. IDF estimated the
occurrence of diabetes in Filipino adults ages 20-79 years of age is around 6.5% and will
increase to 7.9% by 2025; thus, there is an alarming growth of diabetes among adult Filipinos
in the Philippines (Higuchi, 2010). Diabetes mellitus is a metabolic disorder characterized by
chronic high levels of blood glucose levels resulting in abnormalities in insulin secretion,
action, or both (American Diabetes Association, 2014). Additionally, insulin is a hormone
that facilitates the absorption of glucose from blood in skeletal muscle cells and hepatocytes
(Reeven, 1988). There two types of diabetes: Type I (Insulin Dependent Diabetes Mellitus)
and Type II (Non-insulin Dependent Diabetes Mellitus). Chronic effects of diabetes mellitus
include: blood vessel and nerve damages, multiple organ failures, and death (National
Diabetes Data Group, 1979).
Currently, synthetic medicines are made available for diabetic patients- an example of
which being metformin. Metformin is an oral drug used to control blood glucose levels in the
body specifically on Type II Diabetes patients (Viollet, et al., 2012). It is also part of World
Health Organization’s Model List of Essential Medicines as of 2011. Despite being a first-
line treatment for T2DM, metformin has several side effects. Some adverse effects include
lactic acidosis, acute renal failure, and vitamin B12 deficiency (Fitzgerald, Mathieu & Ball,
2009; De Jager, et al., 2010).
3
Plants have also been used as traditional folk medicine for several types of diseases.
The Philippines holds a high number of medicinal plants due to its existing plant diversity
(Balinado & Chan, 2017). Medicinal plants are easy to access, simple to prepare, and
believed to be safe and effective (Savithramma, Linga Rao, & Ankanna, 2011). Moreover,
utilizing medicinal plants in the Philippines would allow for those in the marginalized sector
to receive quality health care and services. (Balinado & Chan, 2017). In 2007, the Philippine
Department of Health (DOH) endorsed ten medicinal plants through the Philippine Institute
of Traditional and Alternative Health Care (PITAHC) under the Traditional Program. The list
includes: Cassia alata (akapulko), Momordica charantia (ampalaya), Allium sativum
(bawang), Psidium guajava (bayabas), Vitex negundo (lagundi), Quisqualis indica L. (niyog-
niyogan), Blumea balsamifera (sambong), Ehretia microphylla Lam. (tsaang gubat),
Clinopodium douglasii (yerba buena), and Peperomia pellucida L. (pansit-pansitan). These
herbs have been tested and clinically proven to have medicinal value (Department of Health,
2007).
P. pellucida, locally known as pansit-pansitan or ulasimang-bato, has several
medicinal properties such as anti-inflammatory (Arrigoni-Blank et al., 2004; Mutee, et al.,
2010), analgesic, antipyretic (Khan, Rahman, & Islam, 2008), antibacterial (Wei, et al.,
2011), anti-cancer (Xu, et al., 2006; Wei, et al., 2011), anti-arthritis (Mutee, et al., 2010) ,
antihyperuricemic (Sio, Sia, & Cortes-Maramba, 2001), anti-ulcer (Roslida & Noor Aini,
2009) and hypoglycemic (Hamzah, et al., 2012). In the Philippine ethnomedicine, P.
pellucida is traditionally used for treating arthritis and lowering of uric acid levels (Heinrich
& Jäger, 2015). The Peperomia species are known to have the presence of xanthones.
Xanthones are secondary metabolites found in lichens, fungi and higher plant families. Their
4
structures are similar to that of flavonoids, but only appear in a limited number of plant
families. Xanthones are often attached with parent polyhydroxylated compounds or with
glycosides (Negi et al., 2013). According to Bo and Liu (2004), xanthones are of great
interest due to its several pharmacological properties.
In a study done by Hamzah and his colleagues (2012), it was presented that P.
pellucida had hypoglycemic properties. Furthermore, a study conducted by De Loreto and
Magbuhat (2016) showed that the plant exhibited hypoglycemic effects on HFD/STZ
induced diabetic mice. As such, this study aims to test a specific phytochemical constituent
of P. pellucida, a xanthone glycoside, and its effect on blood glucose levels and pancreas
histology of HFD/STZ induced diabetic mice. The antihyperglycemic properties of xanthone
glycoside from P. pellucida remain to be acknowledge.
Statement of the Problem
Does xanthone glycoside from P. pellucida (L.) Kunth have a significant effect on
blood glucose levels and pancreas histology of HFD/STZ-induced diabetic Mus musculus?
Research Objectives
In general, this study aims to test the potential effects of xanthone glycoside obtained
from P. pellucida (L.) Kunth on blood glucose levels and pancreas histology of HFD/STZ-
induced diabetic Mus musculus. Specifically, this research seeks (1) to compare the effects of
xanthone glycoside from P. pellucida with commercially sold drug metformin; (2) to
determine the effective dosage of xanthone glycoside for reducing elevated blood glucose in
5
Mus musculus, and (3) to assess the effect of xanthone glycoside on the pancreas histology of
Mus musculus.
Significance of the Study
The use of herbal medicinal products and supplements has continued to expand
rapidly over the past three decades with not less than 80% of the world population depending
on them as primary healthcare (Ekor, 2014). Studies on P. pellucida, one of the top ten
medicinal herbs endorsed by the Department of Health (DOH) (Saguibo and Elegado, 2012)
particularly on its preventive and curative properties makes a high value research as it may
provide new and important leads for drug discovery. To date, there are multitudes of study on
P. pellucida and its various potential medicinal uses. In particular, its potential in reducing
hyperglycemic blood glucose levels has been a topic of discussion in several researches
(Beltran-Benjamin et. al., 2013; Hamzah et. al., 2012; Gbolade 2009) albeit the main
composition of P. pellucida responsible for its anti-hyperglycemic properties was not
discussed. By expanding the prospects on xanthone glycoside, a component of P. pellucida,
and its anti-hyperglycemic effects, novel drugs against Diabetes Mellitus can be discovered.
Scope and Limitations of the Study
The study was limited to the assessment of three different dosages of xanthone
glycoside (10 mg, 20 mg, and 40 mg) obtained from P. pellucida and its anti-hyperglycemic
effects in Mus musculus through measurement of blood glucose levels and analysis of
pancreas histology. The three different dosages, together with commercially sold drug
metformin (40 mg/kg), was compared based on their efficacy. In addition, positive control
6
and experimental groups would be fed with High Fat Diet/Streptozotocin. Lastly, only male
mice aged 8 weeks, and weighing ~35g would be studied.
7
REVIEW OF RELATED LITERATURE
Morphology of Peperomia pellucida
P. pellucida (L.) Kunth, of the Piperaceae family, is a common and annual herb,
native to tropical Asia, Africa, and Central and South America. In the Philippines, it is
commonly known as “pansit-pansitan” or “ulasimang bato”. The plant is erect, usually 15-45
cm long, with fibrous and shallow roots. It has a thread-like but angular trailing stem;
although those growing in rich habitats have succulent round stems. The internodes are
glabrous and usually measure 3-8 cm long. Its leaves are palmately veined, alternate in
phyllotaxy, cordate-shaped, and smooth in texture. The plant possesses tiny greenish-yellow
bisexual flowers which are loosely arranged in a spike inflorescence. Its fruit is a globose
drupe, green when unripe, and turns black as it matures (Theresa-Ibibia, 2012; Dy & Olotu,
2016; Guillermo, 2015).
Chemical Constituents of Peperomia pellucida
A variety of chemical constituents were found in P. pellucida. Preliminary
phytochemical screening revealed that there are secondary metabolites such as tannins,
saponins, flavonoids, phenols, phytosterols, steroids, terpenoids, sesquiterpenes, alkaloids,
and glycosides. Such compounds are known for their potential medicinal properties
(Savithramma, Linga Rao & Ankanna, 2011). The confirmation of such chemical
constituents further supports the medicinal properties of P. pellucida.
Tannins were found to have strong free radical scavenging activities, the ability to
treat bleeding, wounds and skin afflictions, and dysentery (Hu et al., 2004; Scalbert, 1991).
Flavonoids have antioxidant and free radical scavenging properties (Middleton, Kandaswami
8
& Theoharides, 2000). Its mechanism in treating diseases is its ability to inhibit specific
enzymes, simulate certain hormones and neurotransmitters and scavenge free radicals
(Havsteen, 2002). Plant-derived triterpenoids and saponins exhibit anti-inflammatory and
hypocholesterolemic properties (Balandrin, 1996). Meanwhile, alkaloids are the most diverse
group of secondary metabolites. Alkaloids are known to have analgesic and anti-microbial
properties. Alkaloids and its derivatives are also used as muscle relaxants and
parasympathetic agents (Roberts & Wink, 2013; Garba & Okeniyi, 2011).
Dill apiole was another prominent chemical constituent found in P. pellucida
(Francois, et al., 2013; da Silva, et al., 1999). Different oil compositions of P. pellucida from
different countries reveals that dill apiole is a characteristic constituent. The essential oils
found in different origins only significantly different in a few major and minor chemical
constituents. This further supported by a study done by Narayanamoorthi and his constituents
(2015) where apiol is the most common constituent. Apiole is a known organic compound
that was first seen in parsley and dill. It can alleviate amenorrhea but also an abortifacient
(Ragan, 2010.) Another notable chemical constituent that is often found in P. pellucida are
the secoligans. These secoligans are named peperomins. Some examples of which are
Peperomins B and E, which are said to exhibit inhibitory effect on tumor cells. Other effects
include anti-HIV and anti-inflammatory (Xu, et al., 2006).
Xanthone Glycoside
Xanthones are a class of naturally and synthetically-occurring, oxygen-containing
heterocyclic compounds, that are prominent in the field of medicinal chemistry due to their
extensive biological activities. Xanthone compounds always occur in the families
9
Gentianaceae, Guttiferae, Moraceae, Clusiaceae, and Polygalaceae (Negi et. al., 2013). Their
wide usage can be attributed to their chemical structure which allows a variety of substituents
to position on its aromatic ring. Among the compound’s many derivatives include xanthone
glycosides, which is any member of the class of xanthones having one or more glycosyl
residues attached at unspecified positions (Shagufta & Ahmad, 2016). To be more specific,
xanthones glycosides are further classified as either C-glycosides or O-glycosides. In C-
glycosides, a C-C bond links the sugar moiety to the xanthone nucleus and they are therefore
resistant to acidic enzymatic hydrolysis whereas the O-glycosides have typical glycosidic
linkage (Sultanbawa, 1979).
Pharmacological Properties of Xanthone Glycosides
Several studies have elucidated the various applications of xanthone glycosides in
medicine. In a study conducted by Teng and her colleagues (1989), xanthone glycosides were
tested for their anti-platelet activities in washed rabbit platelets and found that it inhibited
platelet aggregation and release reaction. In another study by Lin and his collaborators
(1984), results claimed xanthone glycosides to have a remarkable central stimulant effect in
mice and a depressant effect in rats. In an antimycotic study conducted by Khan and his
associates (2010), they isolated patuloside, a xanthone glycoside from P. pellucida, and
found that it had significant antibacterial activity against both Gram-positive bacteria and
Gram-negative bacteria.
In a similar investigation of Muruganandan and his fellow researchers (2005), they
studied the effect of mangiferin, a xanthone glucoside from the leaves of Mangifera indica,
and its atherogenic potential in streptozotocin-induced diabetic rats. Furthermore, their study
10
showed significant anti-hyperlipidemic and anti-atherogenic activities of the compound. With
chronic administration (14 days), it significantly improved oral glucose tolerance in glucose-
loaded normal rats suggesting its potent antihyperglycemic activity. Their preliminary
investigations, however, showed that rats exhibited signs of depression when administered
with mangiferin with doses beyond 100 mg/kg through the intraperitoneal route. Thus, their
study tested for 10 and 20 mg/kg xanthone glycoside concentration administered
intraperitoneally, which showed no gross signs of toxicity. Moreover, mangiferin was
reported to have poor bioavailability in the oral route in rats (Geodakyan et. al., 1992) and
showed signs of pharmacological effects when administered intraperitoneally (Guha, Gusal,
& Chattopadhyay, 1996).
Diabetes Mellitus
Diabetes mellitus is defined as a group of metabolic diseases characterized by
abnormally high levels of blood glucose or hyperglycemia. Diabetes is commonly caused by
defects in insulin secretion, insulin action, or both (American Diabetes Association, 2014).
There are two types of diabetes mellitus: Type I and Type II. Type I diabetes or juvenile
diabetes, formerly known as insulin-dependent diabetes mellitus (IDDM), is caused by
pancreatic islet β-cell destruction. Ketoacidosis is a common feature of this kind of diabetes,
and often attributed to autoimmune disease. Type II diabetes, formerly known as non-insulin-
dependent diabetes mellitus (NIDDM), is caused by defects in insulin secretion, decreased
sensitivity of insulin target cells, and β-cell dysfunction. This type of diabetes always lead to
insulin resistance (Alberti & Zimmet, 1998). Both types of diabetes lead to hyperglycemia,
polyuria (frequent urination), polydipsia (excessive thirst), ketonuria (presence of ketones in
11
urine), and sudden weight loss, together with gross and unequivocal elevation of plasma
glucose (PG) (National Diabetes Data Group, 1979).
Type II Diabetes Mellitus
Type II diabetes mellitus (T2DM) occurs when the pancreas does not produce enough
insulin. It is the most prevalent form of diabetes, accounting for about 90% of the total
diabetic patients (Stumvoll, van Haeften, & Goldstein, 2005); and can be improved, and in
some instances reversed (Peterson, 2014) by making positive lifestyle choices such as eating
a healthy diet, exercising on a regular basis, and losing excess weight.
To further understand the pathophysiology of T2DM, it is necessary to conceptualize
how glycemia is controlled. Insulin is the principal hormone responsible in mediating blood
glucose levels. For a normoglycemic individual, as blood glucose levels rise, or in the case of
after a meal (2-hour Plasma Glucose of less than 200 mg/dL), insulin levels likewise
increase. Conversely, once blood glucose levels drop, there will be decreased release of
insulin and increased release of glucagon for glycogenolysis or the conversion of glycogen to
glucose (American Diabetes Association, 2017; Lin & Sun, 2009). Specifically, insulin
regulates the uptake of glucose from the blood into the cells. Important to the regulation of
insulin is the sensitivity of pancreatic β-cells to adapt to changes in insulin action.
Gross Morphology and Histology of the Pancreas
In rodents, the pancreas is characterized as a lobular and tan gland suspended in the
mesentery, between the stomach, duodenum and ascending and transverse colons. The gland
is divided into irregular lobes and lobules, with several excretory ducts penetrating the gland
12
(Longnecker, 2014). Unlike the human pancreas that consists of five parts, mouse pancreas is
divided into three parts: the duodenal, gastric, and splenic lobes. However, there are no
definite boundaries that separate each lobe (Nakagawa, 2015).
When examined microscopically, the mouse pancreas is similar to that of the human
pancreas, both containing exocrine and endocrine portions that are enclosed in a fibrous
capsule. Just like most organs, the pancreas is divided into two general parts: the storm and
the parenchyma. The stroma comprises the capsule and associated septa and reticular fibers.
On the other hand, the parenchyma comprises an exocrine and an endocrine portion
(Lehmann et al., 2007).
The pancreatic acinar cells, described as clusters of pyramidal shaped cells with basal
nuclei, represent the exocrine part of the pancreas. Characteristically, these acinar cells have
a basal part that is basophilic due to abundance of rough endoplasmic reticulum, and an
acidophilic apical part due to the presence of secretory granules.
Meanwhile, the Islets of Langerhans, responsible for the endocrine function of the
pancreas, are described as pale, spherical, scattered, and vascularised collections of cells
arranged as anastomosing plates (Kilimnik et al., 2012). The endocrine pancreas contains
five types of cells, namely: alpha cells, beta cells, delta cells, G cells and F cells. Alpha cells
are acidophilic cells responsible for producing glucagon. Antagonistic to its function are the
beta cells which are large, spherical, and the most abundant cells in the islets (>60%),
responsible for the production of insulin. Other cells of the Islets include delta cells, G cells,
and F cells, which produce somatostatin, gastrin, and pancreatic polypeptide respectively. It
is important to take note that these cells of the Islets cannot be differentiated from one
another by routine stains like H&E stain (Dolenšek, Rupnik, & Stožer, 2015).
13
Histopathological Studies of Islets in Type II Diabetes Mellitus
Type II diabetes mellitus subjects manifest both defective insulin action and
abnormalities in their pancreatic islets. Whether islet abnormalities are a primary defect or
are a consequence of defective insulin action is unknown.
In a study by Deng and his colleagues (2004), human pancreatic islets were recovered
from type 2 diabetic cadaveric donors and normal donors, with matching age, BMI, and cold
ischemia time. The two samples were compared, and it was found that there was significantly
less and smaller islets, defined by Lehmann and his colleagues (2007) to be between 50 and
150 μm in humans, recovered from the diabetic donor. Histologically, islets from the diabetic
donor contained a higher proportion of glucagon-producing α-cells. In similar investigations
(Nurdiana et. al., 2017; Jelodar, Mohsen, & Shahram, 2007), the histopathology of diabetic
rat pancreas was examined. The acinar cells were swollen, with almost cells observed
containing vacuoles. Interlobular ducts were lined with flattened epithelium and Islet β-cells
are almost entirely destroyed in STZ-treated (Nurdiana et. al., 2017) and Alloxan-treated
(Jelodar, Mohsen, & Shahram, 2007) rats. Destroyed islets were characterized to be
hyperplastic and hypertrophic, and with vascular congestion or hemorrhage. The Islet
periphery was described to be intruded with skeins of fibrous tissue, while the central portion
infiltrated by lymphocytes (Nurdiana et. al., 2017).
HFD/STZ Mouse Model
The employment of High Fat Diet-Streptozotocin (HFD/STZ) protocol has been
reported by several studies (Skovsø, 2014; Nakagawa, 2015; Kim et. al., 2016; Li et. al.;
2014). Such protocol was classified by Nakagawa (2015) as a Diet in Combination with
14
Chemotoxic Agent Model. Furthermore, according to Wu and Huan’s (2008) investigation,
the HFD/STZ model has been routinely applied to mice. Streptozotocin (STZ) is an antibiotic
that has a diabetogenic property which is characterized by selective destruction of pancreatic
islet β-cells, causing insulin deficiency, hyperglycemia, polydipsia, and polyuria, all of which
mimic human diabetes mellitus (Wu & Huan, 2008). Meanwhile, the high fat diet (HFD)
induces hyperinsulinemia, insulin resistance, and glucose intolerance while promoting
obesity; all these are the conditions during prediabetes (De Loreto & Magbuhat, 2016).
15
MATERIALS AND METHODOLOGY
Plant Extraction and Fractionation
The collection of P. pellucida was done at the University of the Philippines Diliman,
Quezon City, and the aerial parts of the plant samples were verified and authenticated in the
Institute of Biology Jose Vera Santos Memorial Herbarium, College of Science, Diliman,
Quezon City. The aerial parts of the plants were washed and air dried for two weeks and
grounded into powder with a mortar and pestle. About 750 g of ground P. pellucida were
soaked in 7 L 95% methanol for five days. This is performed because xanthone glycosides
are usually crystallized from MeOH (Negi et. al., 2013). The crude extracts were stored in
erlenmeyer flasks at low temperatures (5-15 oC) before use.
Succeedingly, the methanolic crude extract was filtered using a Whatman Filter #1
and evaporated using a rotary evaporator to obtain a blackish-green mass.
Purification of Xanthone Glycoside
The mode of extraction of xanthone glycoside was based on the selective partitioning
of glycosides by Kuwajima and his colleagues (1992). The initial solid isolate obtained from
the rotary evaporator, and which weighed 38.04 g, was resuspended in a 3L-solution of 30%
Methanol : 70% water. This solution was subjected to solvent-solvent extraction using a
separatory funnel, with the solution as the aqueous solvent and hexane as the organic solvent.
The methanol-water solution and hexane were mixed and allowed to stand until two definite
layers was seen. The lower layer, also known as the organic layer was discarded. This step
specifically removes wax, lipids, and fatty acid constituents of the plant material. The upper
16
layer, also known as the aqueous layer, was collected and subjected to another solvent-
solvent extraction, this time, chloroform as the organic solvent.
The aqueous aliquot from the first extraction is mixed with chloroform and allowed to
stand and separate into two definite layers. From this system, the lower layer was discarded,
removing hydrophobic secondary metabolites such as terpenoids, carotenoids, and phenols.
The upper layer or aqueous layer was obtained and subjected to a final solvent-solvent
extraction system.
At this point, a solution of 90% water and 10% aqueous aliquot from the second
extraction was made. This solution served as the aqueous layer while butanol served as the
organic layer. This mixture was allowed to stand in a separatory funnel until two definite
layers were seen. This time, the organic layer or the lower layer is collected for final
purification because glycosides are butanol-soluble compounds.
The butanol fraction was evaporated using a rotary evaporator where 700 mg of a
blackish-green mass was obtained. To verify the identity of the mass obtained, 30 mL of the
butanol fraction was submitted to the Institute of Pharmaceutical Sciences, National Institute
of Health, Manila for phytochemical analysis. From the results obtained, only glycosides
tested positive, verifying that the isolate obtained was indeed purified glycoside.
From there, we obtained the percent yield of xanthone glycoside from the glycosides
of Peperomia pellucida. Based on the study of Khan and his associates (2010), the xanthone
glycoside content of P. pellucida was found to be at 1% of the total glycosides. Using this
information, we computed the amount of xanthone glycoside, through ratio and proportion,
present in the obtained 700 mg of the blackish-green mass confirmed to be pure glycosides.
17
After computation, we found out that our compound contained 0.075 mg of pure xanthone
glycoside.
Acclimatization of Mice
Thirty (30) male Mus musculus (ICR-Strain Laboratory Mouse), aged 6 to 8 weeks
old, approximately weighing 20-30 g, were obtained from the National Institutes of Health,
University of the Philippines Manila. The mice were housed individually in plastic cages,
each with 8.5 inches x 5.5 inches x 5.9 inches floor area with autoclaved wood shavings as
bedding, at the College of Public Health Animal House, University of the Philippines Manila.
The mice were acclimatized for one week following standard conditions: Temperature
ranging from 18-26 oC; Relative humidity at 50 ± 5%; Light intensity at 12 hours light : 12
hours dark cycles. The temperature was maintained by an air conditioning unit while
fluorescent lights were for the photoperiodicity of the mice. The mice were fed with high fat
diet (HFD) food pellets and given access to water. The HFD food pellets were composed of
58% fat from lard, 25.6% carbohydrates, and 16.4% protein. All experimental procedures
were checked and approved by the Institutional Animal Care and Use Committee (IACUC)
of the National Institute of Health.
Induction of Diabetes
Diabetes was induced using Streptozotocin (STZ) together with high fat diet (HFD).
After two weeks of consumption of HFD, the mice were fasted for 20 hours and were given
an intraperitoneal injection of STZ (40 mg/kg) for a span of five days. STZ was dissolved in
0.05 M citrate buffer at pH 4.5 (Byrne, et al., 2015). Each mouse was held in dorsal position
18
during the intraperitoneal injection of STZ. The injection site was swabbed with povidone-
iodine solution, and then STZ were injected in the caudal abdominal cavity of the mouse with
a sterile syringe (Abeeleh et al., 2009). Blood glucose were checked after five days of STZ
treatment for confirmation of diabetes. Diabetic mice were then randomly assigned and
distributed to different treatment groups.
Experimental Set-up
Thirty (30) male ICR Mus musculus were distributed into six groups with five
individuals each. Group A served as the negative control. This group was fed with a standard
diet of quality mice pellets obtained from local pet stores. For succeeding groups, instead of
being fed with a standard diet of quality mice pellets, high fat diet was used. The HFD food
pellets were composed of 58% fat from lard, 25.6% carbohydrates, and 16.4% protein.
Groups B, C, D, and E would serve as the treatment groups. Group B were fed with STZ,
HFD, and metformin. Meanwhile, for Group C, mice were fed with STZ, HFD, and 10 mg
xanthone glycoside. For Group D, mice were fed with STZ, HFD, and 20 mg xanthone
glycoside. As for Group E, mice were fed with STZ, HFD, and 40 mg xanthone glycoside.
The last group, Group F, served as the positive control and would consist of mice fed with
Streptozotocin (STZ) and high fat diet (HFD).
The reference drug was metformin (40 mg/kg) (De Loreto & Magbuhat, 2016) that
was purchased from Mercury Drug Store. It was administered via intraperitoneal injection,
on a daily basis, for three weeks, by dissolving it in distilled water containing 0.9%
(weight/volume) sodium chloride (Cheng, et al., 2006). Meanwhile, xanthone glycoside was
administered through intraperitoneal injection for a span of three weeks. This mode of
19
administration was based on the studies of Geodakyan and his colleagues (1992) and Guha
and his associates (1996).
Obtaining Body Weight
The weight of the mice was closely monitored during the entire course of the study.
Specifically, we measured them closely at the beginning of the experiment, before and after
treatment with metformin and xanthone glycoside of selected groups, and before the mice’s
cervical dislocation. From these data, the initial and final body weight as well as the before
and after treatment weight data was compared respectively for statistically significant
changes.
Blood Glucose Analysis
Blood samples were drawn from the periorbital sinus of the mice and closely
monitored weekly for 6 weeks. Specifically, blood glucose before and after treatment with
metformin and xanthone glycoside were compared for statistically significant changes. Blood
glucose levels were determined using Advan electronic glucometer.
Examination of Gross Morphology and Histopathology of Mice Pancreas
After treatment, the mice were subjected to overnight fasting and blood was drawn
for blood glucose analysis. They were killed via cervical dislocation, anesthetizing them first
with 30 mg/kg Zoletil injected intraperitoneally. The pancreas was excised for
histopathological analysis.
20
Table 1. Scoring system for histological alterations as indicators of damages in the
pancreatic acinar and islets of Langerhans of diabetic male ICR mice modified by Professor
Benjamin.
Parenchymal Necrosis 0 - No necrosis
0.5 - Focal occurrence of 1–4 necrotic cells
1 - Diffuse occurrence of 1–4 necrotic
cells/HPF
1.5 - Same as 1 + focal occurrence of 5–10
necrotic cells/HPF
2 - Diffuse occurrence of 5–10 necrotic
cells/HPF
2.5 - Same as 2+ focal occurrence of 11–16
necrotic cells/HPF
3 - Diffuse occurrence of 11–16 necrotic
cells/HPF
3.5 - Same as 3 focal occurrences of >16
necrotic cells/HPF
4 - ≥ 16 necrotic cells
Steatosis 0 – Absent
1 - 25% has steatosis
2 - 50% has steatosis
3 - 75-100% present
Fibrosis 0 - No fibrosis
1 - Focal, <10% of the pancreas parenchyma
2 - Mild, between 11 to 50% of the pancreas
parenchyma
3 - Diffuse, between 51 to 75% of the
pancreas parenchyma
4 - Severe, >76% of the pancreas parenchyma
Hemorrhage 0 – Absent
1 - Present
Acinar Cells 1 - No acinar cell destruction
2 - Acinar cell destruction <25% of acinar
cells
3 - Acinar cell destruction <26–50% of acinar
cells
4 - Acinar cell destruction <51–75% of acinar
cells
5 - Acinar cell destruction >75% of acinar
cells
21
The excised pancreas were examined for morphological alterations. After which, the
pancreas were fixed in 10% buffered formaldehyde and brought to Hi-Precision Diagnostics
for histological processing of the selected tissue for histological examination. The tissue
sample was sectioned, stained with hematoxylin and eosin, and analyzed under the light
microscope. The histological slides were examined for fibrosis, damage in acinar cells, fat
deposits, parenchymal necrosis, hemorrhage and lymphocyte infiltration. In addition, the
diameter of the islets of Langerhans was measured with a micrometer. The mice pancreas
tissue were analyzed by using a histological alteration scoring system modified by Prof.
Benjamin (De Loreto & Mangubat, 2016).
The index scores were subjected to non-parametric tests, Kruskal-Wallis H Test
followed by Mann-Whitney U Test, respectively, to determine if there are significant
differences in between groups, and to determine specifically what groups bring about the
significance.
Statistical Analysis
All changes in weight, and blood glucose values before and after treatments were
subjected to paired T-test. Final body weight, blood glucose, and islet of Langerhans
diameter values were analyzed by one-way ANOVA followed by Tukey’s HSD Test. While
the histological index scores were subjected to Kruskal-Wallis H test, followed by Mann-
Whitney U test.
22
RESULTS
Body Weight
The body weights of all mice in all groups were noted at the first week of the
experiment and were monitored throughout the duration of the study. To know whether Type
2 Diabetes have been successfully induced in mice, the mean body weights were measured
before and after introduction of STZ and HFD. Figure 1 shows that all groups have exhibited
an increase in weight. After the introduction of STZ to the treatment groups, the mean body
weight of the control group fed with standard diet (Group A) increased by 14.07%, while the
mean body weight of the untreated diabetic group (Group F) increased by 14.28%. The mean
body weights of the diabetic groups treated with metformin, 10 mg/kg xanthone glycoside,
20 mg/kg xanthone glycoside and 40 mg/kg xanthone glycoside increased by 27.37%,
14.50%, 16.00%, and 14.40% respectively. Eventually, the mean body weights were
subjected to paired t-test. As seen in the figure 1, all the groups exhibited a significant
increase in body weight.
After successful induction of Type 2 diabetes, the mice received various
concentration of xanthone glycoside to know whether this compound can reduce not only
body weight but even blood glucose level mean body weight of diabetic mice. Figure 2
shows the mean body weight of diabetic mice before and after introduction of xanthone
glycoside. The results showed that there is a decrease in weight by 5.17% and 1.44% in
Groups B and C respectively, while an increase in weight by 11.85% and 7.97% for Groups
D and E respectively. The mean body weights before and after treatment were also subjected
to paired-T test. The results show that only Groups A, D and F exhibited significant increases
in body weight after the treatment period.
23
Figure 1. Mean body weights (in g) of all groups of male ICR Mus musculus from the week after
acclimatization and after STZ/HFD induction. Different letters denote significant changes within each group
using Paired T-test (p<0.05). ANOVA Test (p<0.05) yielded no significant differences between groups.
Figure 2. Mean body weights (in g) of groups of male ICR Mus musculus from the initial and final week of
treatment with xanthone glycoside. Different letters denote significant changes within each group using Paired
T-test (p<0.05). ANOVA Test (p<0.05) yielded no significant differences between groups.
24
Blood Glucose Levels
Blood glucose levels of all mouse subjects were tested after acclimatization and were
closely monitored weekly throughout the study. Similar to the body weight, mean glucose
level were also determined before and after introduction of high fat diet and STZ and before
and after treatment. Figure 3 exhibited an increase of blood glucose levels across all
treatment groups. Comparison of before and after STZ induction blood glucose levels of all
mice showed 16.67% increase for Group A, 104.27% increase for Group B, 124.22%
increase for Group C, 88.64% increase for Group D, 147.95% increase for Group E, and
3.33% for Group F. Upon subjecting the results to statistical analysis, results show that only
Group D and E have significant increase in blood glucose after injecting STZ and feeding
HFD.
After induction of diabetes, the mice were given different xanthone glycoside
concentrations, 10 mg/kg, 20 mg/kg and 40 mg/kg, for three weeks to test whether or not
blood glucose level change or not. Figure 4 shows an increase blood glucose levels in all
groups except Group D. The mean blood glucose level before and after treatment shows that
Group A had 9.47% increase, Group B had 20.80% increase, Group C had 11.27% increase,
Group D had 11.74% decrease, Group E had 63.97% increase, and lastly, Group F had
17.94%. Upon application of paired-T test, only Groups D and E have significant changes in
blood glucose levels before and after treatment. The results of the one-way ANOVA show a
significant difference between Groups A and E.
25
Figure 3. Mean blood glucose levels (mg/dL) of all groups of male ICR Mus musculus before and after STZ
induction. Different letters denote significant changes within each group using Paired T-test (p<0.05). ANOVA
(p<0.05) yielded no significant difference between groups.
Figure 4. Mean blood glucose levels (mg/dL) of all groups of male ICR Mus musculus before and after
treatment of xanthone glycoside. Different letters denote significant changes within each group using Paired T-
test (p<0.05). Different numbers denote significant changes in between groups using ANOVA (p<0.05).
26
Gross Morphology of Pancreas
All mice pancreas were initially subjected to gross morphological examination using
a stereoscope. The following characteristics were noted during the gross analysis: color,
shape, size, and the presence or absence of black blotches which are gross manifestations of
necrosis and hemorrhage. Sizes were quantitatively measured with a ruler, and later on
categorized as small (less than 1 cm), medium (1 - 3 cm), or large (greater than 3 cm) based
on the scale of Bowen (2017).
Group A exhibited a normal tan color of the pancreas, lobular shape, and was
measured to be of medium size at 2.82 cm. No red or black blotches were observed in the
pancreas of group A. These features are in accordance to the descriptions of Bowen (2017) of
normal gross pancreas characteristics. Group B exhibited a pancreas that is whitish in color
across the entire pancreas, lobular shape, medium sized at 2.75 cm, and with black to red
blotches specifically observed at the head and tail of the pancreas. Particularly, blotches of
Group B were dominant at the tail region of the pancreas and minimal at the head region.
Group C exhibited a pancreas that is whitish in color across the entire pancreas, lobular
shape, medium-sized at 2.70 cm, and with black to red blotches specifically observed
minimally at both the head and body of the pancreas. Group D exhibited a pancreas that has
whitish spots, lobular shape, medium size at 2.80 cm, and with black to red blotches
observed at the head and body of the pancreas. Group E exhibited a pancreas that has whitish
spots, lobular shape, medium size at 2.50 cm, and with black to red blotches observed at the
uncinate, body, and tail region of the pancreas. Group F exhibited a pancreas that is pinkish
in color, lobular in shape, medium-sized at 2.65 cm, with presence of black to red blotches
observed specifically at the tail region of the pancreas. In terms of frequency of blotches,
27
Group F exhibited the most abundant blotches, suggesting extensive necrosis and
hemorrhage. Next to Group F is Group B, followed by groups E, C, and D, arranged with
decreasing prevalence of blotches.
Figure 5. Gross Morphology of the Pancreas. The black arrow shows the areas where black-red blotches are
seen. The letters U, H, B and T signifies uncinate, head, body and tail of the pancreas. A: Pancreas of Group A
which exhibits normal gross morphological appearance. It is characterized as tan in color and lobular in shape,
with absence of black to red blotches (10x). B: Pancreas of Group B which is whitish in color, lobular in shape,
and exhibits black to red blotches particularly dominant at the tail and minimal on the head region of the
pancreas (10x). C: Pancreas of Group C which is whitish in color, lobular in shape, and with black to red
blotches at the head and body of the pancreas (10x). D: Pancreas of Group D which is whitish in color, lobular
in shape, and with minimal black to red blotches at the head and body of the pancreas (10x). E: Pancreas of
Group E which is whitish in color, lobular in shape, and with black to red blotches at the uncinate, body, and
tail of the pancreas (10x). F: Pancreas of Group F which is characterized as pinkish in color, lobular in shape,
and with black to red blotches at the tail region of the pancreas (10x).
28
Islet Diameter
During the histological analysis, islet diameter was measured. It was found that
Group C, the group administered with HFD, STZ, and 10 mg/kg xanthone glycoside, had the
highest mean islet diameter at 191.10 μm. This group was followed by Group D (HFD + STZ
+ 20 mg/kg xanthone glycoside) at 186.04 μm Group A (Negative Control) at 180.46 μm,
Group E (HFD + STZ + 40 mg/kg xanthone glycoside) at 163.04 μm, and Group B (HFD +
STZ + 40 mg/kg metformin) at 141.68 μm. Group F, the positive control, had the lowest islet
diameter at 81.39 μm.
Statistical analysis was performed using ANOVA, where a statistically significant
difference among the groups. Post-hoc analysis specifically revealed that Groups C and F,
and Groups D and F have respectively significant differences in terms of islet diameter.
Figure 6. The mean diameters of the pancreatic Islets of Langerhans per male ICR mice group. Different
numbers denote significant changes in between groups (p<0.05).
29
Histopathology of Pancreas
After gross examination of the pancreas, microscopic examination was performed. It
was found that Group A (Negative Control) exhibited normal pancreas architecture. Both the
Islets of Langerhans and the surrounding acinar cells remained intact and free of
abnormalities. Meanwhile, histological abnormalities such as parenchymal necrosis,
steatosis, fibrosis, hemorrhage, lymphocyte infiltration, and acinar cell destruction have been
observed among Groups B to E (Treatment Groups) and Group F (Positive Control).
Figure 7. The mean histological scores of pancreatic tissue samples from HFD/STZ-induced hyperglycemic
male ICR mice with selected groups treated with xanthone glycoside obtained from P. pellucida. Different
numbers denote the similar groups (p<0.05).
30
Figure 8. Representative Micrographs of Hematoxylin and Eosin-Stained (H&E) Pancreatic Islets of Mus
musculus. The red arrow signifies hemorrhage, black arrow signifies necrosis, yellow arrow signifies fibrosis
and white arrow signifies lymphocyte infiltration. A: The islet of Group A exhibits a normal histological
appearance (400x). B: The islet of Group B (metformin) has hemorrhage and a few necrotic cells (400x). C:
The islet of Group C (XG10) exhibits several necrotic cells and fibrosis (400x). D: The islet of Group D
(XG20) shows cell necrosis (400x). E: The islet of Group E (XG40) shows fibrosis, necrotic cells and cells
undergoing hypertrophy (400x). F: The islet of Group F has shown a remarkable decrease in islet diameter as
well as presence of hemorrhage and fibrosis (400x).
31
Figure 9. Representative Micrographs of Hematoxylin and Eosin-Stained (H&E) Pancreatic Acinar Cells
of Mus musculus. The red arrow signifies hemorrhage, black arrow signifies necrosis, yellow arrow signifies
fibrosis and white arrow signifies lymphocyte infiltration. IL shows the intralobular septum A: The acinar cells
of Group A exhibits a normal histological appearance (400x). B: The acinar cells of Group B (metformin) has
exhibited necrosis and fibrosis(400x). C: The acinar cells of Group C (XG10) exhibits lymphocyte infiltration,
cell necrosis and fibrosis (400x). D: The acinar cells of Group D (XG20) shows hemorrhage, lymphocyte
infiltration, several necrotic cell, fibrosis and hypertrophic cells (400x). E: The acinar cells of Group E (XG40)
shows necrotic cells and cells undergoing hypertrophy (400x). F: The acinar cells of Group F has shown
necrotic cell, fibrosis and hemorrhage (400x).
IL
32
Table 2. Summary of the histological alterations observed in pancreatic tissues treated with
xanthone glycoside obtained from P. pellucida methanolic extract.
Histological
Alterations
A
(Negative
Control)
B
(HFD/ STZ
+
Metformin)
C
(HFD/ STZ
+ 10 mg/kg
XG)
D
(HFD/ STZ
+ 20
mg/kg)
E
(HFD/ STZ +
40 mg/kg
XG)
F
(Positive
Control)
Parenchymal
Necrosis
Absent Present
(32.5%)
Present
(62.5%)
Present
(50%)
Present
(62.5%)
Present
(50%)
Fat Deposits /
Steatosis
Absent Present
(18.95%)
Present
(8.85%)
Present
(22.50%)
Present
(55.80%)
Present
(61.25%)
Fibrosis Absent Present
(27%)
Present
(25.75%)
Present
(44.29%)
Present
(33.55%)
Present
(37.81%)
Acinar
Damage
Absent Present
(22.06%)
Present
(18.35%)
Present
(37.76%)
Present
(29.50%)
Present
(25.66%)
Hemorrhage Absent Present Present Present Present Present
Lymphocyte
Infiltration
Absent Present Present Present Present Present
Average
Histological
Scores Per
Group
0.2 1.42 1.58 1.67 1.92 1.83
33
DISCUSSION
Induction of Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM) is clinically characterized by reduced insulin
secretion, decreased sensitivity of insulin target cells and β-cell dysfunction (Alberti &
Zimmet, 1998). Other characteristics may include obesity and, at some degree, β-cell failure.
(Yu et al., 2017). Induction of T2DM through high fat diet (HFD) and multiple low doses of
Streptozotocin (STZ) mimics the pathological progression of diabetes in humans. HFD
allowed obesity, hyperinsulinemia and insulin resistance to develop in mice subjects
(Srinivasan, et al., 2005). On the other hand, STZ directly damages the β-cells which results
in hyperglycemia and hypoinsulinemia. Depending on the dose, STZ can induce diabetes in
two ways: 1) At a singly high dose, STZ acts as an alkylating agent directly to the β-cell, and
2) at multiple low doses, STZ elicits immune and inflammatory responses. Destruction of β-
cells and induction of hyperglycemia are mainly caused by lymphocyte infiltration in
pancreatic tissues, especially in the islets (Graham, et al., 2011).
In this study, two weeks of HFD were done to induce insulin resistance in mice
subjects, while the 5-day STZ treatment led to dysfunctional pancreatic islets.
Effect on Body Weight
Body weights of all groups were obtained after acclimatization and after STZ/HFD
induction of experiment. In addition to this, body weights of Groups B, C, D, and E were
noted before and after treatment with metformin and xanthone glycoside.
In this study, a significant increase of 14.07%, 27.37%, 14.50%, 16.00%, 14.40%,
and 14.28% between the initial and final body weights (g) of Groups A, B, C, D, E, and F
34
respectively, were observed. Many factors are known to influence body weight in mice, and
some of the strongest and best-known factors are age, sex, and diet. For instance, old mice, or
mice that are older than 8 weeks, are significantly heavier than young mice mostly because of
the increase in fat mass due to normal body metabolism. There are also sex-specific
differences in mice body weight such that male mice tend to have larger bodies and thus have
greater propensity to gain more weight than female mice. Diet can also have a large impact
on body weight (Yang et al., 2014; Houtkooper et al., 2011; Korou et al., 2013). In this study,
treatment groups (Groups B, C, D, and E) and the positive control (Group F) were fed with
high fat diet, specifically composed of 58% fat from lard, 25.6% carbohydrates, and 16.4%
protein, which promoted weight gain. This weight gain associated with hyperglycemic blood
glucose levels suggests successful induction of Type 2 Diabetes.
Meanwhile, no significant changes in body weight have been observed in Groups B,
C, and E before and after treatment administration. Specifically, there was an insignificant
decrease in body weights for Groups B and C; while an insignificant increase was observed
in Group E. Meanwhile, a significant increase of 11.85% in body weight was observed in
Group D.
The decrease in body weight observed in Group B can be attributed to metformin, a
prescription medication used to treat Type 2 Diabetes by increasing insulin sensitivity.
Associated side effects of this drug which include a decreased appetite and an upset stomach,
may lead to modest reduction in weight — thus accounting for the insignificant decrease in
body weight observed in Group B (Seifarth, Schehler, & Schneider, 2013).
Similarly, an insignificant decrease was observed in the body weight of Group C. On
the other hand, an insignificant increase in body weight was observed for Group E. These
35
insignificant changes may therefore imply the dose-dependent nature of xanthone glycoside
in terms of its control in body weight.
Interestingly, Group D, the group administered with 20 mg/kg xanthone glycoside,
was found to have a significant increase in body weight. This result is corroborated by the
studies of Dineshkumar and his colleagues (2010), Muruganandan and his fellow researchers
(2005), and Ratwita and his associates (2017) who all found a significant increase in body
weights of STZ-induced diabetic rats after treatment with mangiferin, a xanthone glucoside
found in the family Anacardiaceae. All three studies agree in their claim that mangiferin,
specifically of 20 mg/kg, was found to significantly improve body weight loss.
Effect on Blood Glucose Levels
Blood glucose concentration level is defined as a function of the rate of glucose
entering circulation balanced by the rate of glucose removal from circulation. Glucose comes
from three major sources: intestinal absorption, glycogenolysis and gluconeogenesis. Normal
muscle glucose metabolism involves the activation of the glucose transport system which
leads glucose to insulin target cells. An increase in blood glucose levels means that the rate of
glucose entering is greater than the rate of removal. These glucose influxes are regulated by
hormones such as insulin and glucagon (Aronoff, et al., 2004). In this experiment, the high
levels of blood glucose are attributed to β-cell destruction by the STZ and increased levels of
free fatty acids by the high fat diet.
Induction of high fat diet causes hyperlipidemia, a blood lipid disorder that shows an
abnormally high levels of blood lipid in the blood, in mice. Presence of hyperlipidemia is a
high-risk factor for obesity and T2DM (Park & Lee, 2013). In a study done by Buettner and
36
his colleagues (2006), lard-based diet led to a pronounced manifestation of obesity and
insulin resistance. Rodents with this type of high fat diet gained more weight, had high
plasma glucose levels and showed inefficient insulin-induced glucose uptake. Lard contains
high amounts of saturated fatty acids which can increase blood cholesterol levels in the body.
Overnutrition on fatty acids can eventually lead to ectopic fat accumulation which promotes
insulin resistance in organs such as the liver. Increased ectopic fat levels in the body also
affect the primary functions of pancreatic β-cells and muscles (Skovsø, 2014). As a
consequence, skeletal muscles will have impaired glycogen synthesis which can be
associated to insulin resistance. In prediabetic or early stages of T2DM, insulin resistant
muscles redirect glucose to the liver. The liver promotes lipogenesis which induces hepatic
insulin resistance. Instead of promoting glycogenesis, the liver promotes gluconeogenesis
which causes hyperglycemia to the body (Defronzo & Tripathy, 2009; Skovsø, 2014).
Moreover, streptozotocin (STZ), a potent and selective β-cell toxin which causes necrosis of
β-cells, was used in this study to decrease islet activity, lowering antioxidants such as
superoxide dismutase, catalase, and glutathione peroxidase. Destruction of pancreatic β-cells
eventually leads to decreased synthesis and secretion of insulin to the bloodstream (Qinna &
Badwan, 2015).
In the pathogenesis of diabetes, the chronic exposure to hyperglycemia results in the
generation of reactive oxygen species which in turn results in oxidative stress in β-cells, and
later as β-cell dysfunction. This phenomenon is known as glucose toxicity and results to
impaired insulin secretion by the β-cells and ultimately proceeds as diabetes. In a previous
study by Benjamin and her fellow researchers (2013), the potential antioxidant effect of P.
pellucida crude extract was confirmed. Their study showed that P. pellucida crude extract
37
elevated superoxide dismutase (SOD), and catalase (CAT) activity, which are considered as
first line defense antioxidants (Ighodaro & Akinloye, 2017). Moreover, according to Khan
and his colleagues (2010), xanthone glycosides found in P. pellucida were found to have an
antioxidative property by inhibiting lipid peroxidation and scavenging radicals. With these
information, we can deduce that the efficacy of xanthone glycosides as an antihyperglycemic
agent is based on its antioxidant properties. In particular, xanthone glycosides as
antioxidants, increase activity in the islet by increasing superoxide dismutase, catalase, and
glutathione peroxidase, thereby suppressing β-cell dysfunction and providing possible
intervention to hyperglycemia or diabetes (De Loreto & Magbuhat, 2016). This is
substantiated by the result of the study of Muruganandan and his associates (2005) which
showed the potent antihyperglycemic property of mangiferin, a xanthone glucoside, against
STZ-induced diabetic rats.
To date, the most commonly prescribed drug administered in the treatment of non-
insulin-dependent diabetes mellitus (NIDDM) is metformin. It improves glycemic control,
specifically through non-pancreatic mechanisms, thus it does not cause hypoglycemia and
hyperinsulinemia -- which are common side effects of other antidiabetic drugs (Nasri &
Kopaei, 2014; Gong et al., 2012). Metformin works mainly by decreasing hepatic glucose
production through the reduction of gluconeogenesis, glycogenolysis, and fatty acid
oxidation. According to a study of Nasri and Kopaei (2014), metformin specifically
phosphorylates and activates the enzyme adenosine monophosphate kinase (AMPK) which is
an inhibitor of vital enzymes involved in gluconeogenesis, glycogenolysis, and fatty acid
oxidation in the liver. It is important to take note that although metformin largely acts on
38
hepatic metabolism, it is not metabolized by the liver, and is excreted unchanged in the urine
and feces (Gong et al., 2012; Rice et al., 2011).
Outside the liver, metformin works by reducing intestinal absorption of glucose.
According to several studies (Gong et al., 2012; McCreight et al., 2016; Bailey, Wilcock, &
Scarpello., 2008), metformin works by increasing glucose utilization by the intestine,
particularly through anaerobic glucose metabolism, which contributes to the reduction of
glucose intestinal absorption from the luminal into the serosal side of the intestine.
Metformin also works by increasing insulin-mediated glucose uptake in the peripheral tissues
by increasing translocation of glucose transporters, notably GLUT-4, thereby increasing
cellular glucose uptake. Several side effects of metformin include modest weight reduction,
dyspepsia, nausea, and diarrhea (Gong et al., 2012).
In this study, blood glucose was monitored weekly after acclimatization until the
death of the mice. Particularly, blood glucose levels before and after STZ administration
were statistically compared, as well as blood glucose levels before and after treatment. As
seen in Figure 3, blood glucose levels before and after STZ administration, increased for all
groups; however, only Groups D and E exhibited significant increases in this aspect. This
trend after STZ administration was expected due to the nature of STZ as a potent β-cell toxin,
capable of decreasing islet activity and thereby impairing insulin secretion. In mammalian
cells, STZ uptake and metabolism involves free radical generation which causes DNA and
chromosomal damage. Particularly, STZ toxicity is related to the glucose moiety in its
chemical structure which enables it to enter the beta cell via the low affinity glucose 2
transporter in the plasma membrane. Since β-cells of the pancreas are more active than other
39
cells in taking up glucose, they are more sensitive than other cells to STZ damage (Eleazu et
al., 2013).
As for blood glucose levels before and after treatment, results show insignificant
increases in Groups A, B, C, and F. This means that, statistically, these mentioned groups
had the same blood glucose levels before and after administration of treatment. This is
expected of Group A, because being the negative control, it was not administered any
treatment. As for Group B, an unexpected increase in blood glucose levels was observed.
Although this increase was statistically insignificant, a decrease is theoretically expected
after treatment with metformin.
One crucial information which is key to understanding this result is the mechanism of
pancreatic β-cell proliferation. Prior to treatment with metformin, Group B was fed with HFD
and injected with STZ. The combined effects of HFD and STZ on the pancreas resulted in
the toxicity of the islets, particularly the β-cells, resulting to impairment of insulin
production. Normally, pancreatic β-cells have normal proliferative potential after a short
quiescence period of several days. However, this quiescence period is lengthened with age.
Further analysis suggests that replicated β-cells are less likely to divide again compared to
unreplicated β-cells, and that they enter a prolonged refractory period, estimated in months
(Salpeter et al., 2010; Teta et al., 2007). This idea corroborates the idea of a study by Desgraz
and Herrera (2009), suggesting that a single β-cell undergoes only two or three replications
over the course of its lifetime. Considering the age of the mice during the time of
administration of STZ, they were about 10 weeks old, an adult age for mice (McCutcheon &
Marinelli, 2009). From this data, we can deduce that the age of the mice affected the normal
proliferative potential of the β-cells. Thus, the toxicity-induced and impaired β-cells at the
40
time of HFD and STZ administration might have remained in the pancreas of Group B,
accounting for the insignificant increase in blood glucose rather than the expected significant
decrease in blood glucose levels.
In the experiment, Groups C, D, and E, or groups administered with 10, 20, and 40
mg/kg xanthone glycoside respectively, exhibited insignificant increase, significant decrease,
and significant increase in blood glucose levels, respectively.
The principle of drug optimal dose can be used to explain the results in these
treatment groups. Notably, only Group D, administered with 20 mg/kg xanthone glycoside,
exhibited a significant decrease in blood glucose levels. This result is corroborated by the
studies of Dineshkumar and and his colleagues (2010), Muruganandan and his fellow
researchers (2005), and Ratwita and his associates (2017) who all claim that mangiferin, a
xanthone glucoside, specifically of doses 20 mg/kg is an effective antihyperglycemic agent.
As for Groups C and E, non-optimal doses of xanthone glycoside have been
administered. Because Group C had been administered only 10 mg/kg xanthone glycoside—
a dose lower than the optimal— the effects of xanthone glycoside were not fully maximized.
This is reflected on the insignificant increase in blood glucose levels after treatment.
Meanwhile, Group E, administered the highest dose of xanthone glycoside at 40 mg/kg,
exhibited a significant increase in blood glucose levels. This group may have been provided a
toxic dose. This can be corroborated by a study of Pal, Sinha, and Sil (2013) who observed
that high doses of mangiferin, specifically 50 mg/kg promotes Pb(II)-induced hepatic
damage. From this information, we can agree with Daughton and Ruhoy (2013) that reduced
doses of drugs help prevent adverse side effects, drug diversion, and poisonings.
41
Therefore, the results obtained reflect that xanthone glycoside’s potency as an
antihyperglycemic agent is concentration or dose-dependent. This also suggests that 20
mg/kg dose of xanthone glycoside is the most effective of the three doses.
As for Group F, it exhibited an insignificant increase in blood glucose levels.
Theoretically, this should have been a significant increase since no intervention or treatment
was administered in this group. A principle that can explain the results obtained in this group
is the associated genetic variability in the strain of mice used. The mice utilized in this
experiment is ICR mice, a strain of albino mice, oftenly used in pharmacology and toxicity
studies, safety and efficacy testing, cancer research, aging studies, transgenic experiments,
and gene mapping strategies. This specific strain of mice exhibits genetic diversity and thus it
is helpful in product safety testing because its responses are reflective of the human
population (Lee et al., 2017). This genetic variability of the ICR mice strain suggests that
different individuals may respond to different administered drugs, which explains the
unprecedented insignificant increase in blood glucose levels.
It is also important to compare, that while toxicity-induced β-cells have remained in
groups administered with STZ, Group B, administered with Metformin did not have a
profound effect on blood glucose levels as compared with Group D, administered the optimal
dose of xanthone glycoside. This suggests that an optimal dose of xanthone glycoside is
better than metformin in terms of antihyperglycemic activity.
Pancreas Morphology, Histology and Islet Diameter
Pancreatic gross morphology and histology is reflective of the condition of the organ
and its capability of carrying out its functions. In this study, observed gross morphological
42
and histological alterations from the normal pancreatic architecture suggests an underlying
pathology. Observed alterations in the gross morphology of the pancreas include deviations
from the normal tan color of the organ and the presence of black to red blotches, indicative of
necrosis and hemorrhage. Meanwhile, observed alterations in the histology of the pancreas
include parenchymal necrosis, steatosis, fibrosis, hemorrhage, lymphocyte infiltration, and
acinar cell destruction.
Chronic exposure to hyperglycemia, defined by Davidson and his colleagues (2016)
as 3 weeks or more, eventually leads to a phenomenon known as glucose toxicity (Robertson
et al., 2003). This phenomenon is marked by a decrease in insulin secretion by the pancreatic
β-cells and an increase in insulin resistance. Concurrently, the excessive glucose is able to
react with amino groups specifically through glycosylation. This process leads to protein
modification, which results in functional changes in enzymatic activity, production of
reactive oxygen species, and increased vulnerability to oxidative stress. With the
administration of STZ, a potent selective β-cell toxin, β-cell compensation or the increase in
β-cell mass and insulin secretion is halted. With the presence of a β-cell toxin, and the
continuous administration of HFD leading to oxidative stress, total β-cell dysfunction ensued
leading to alterations in normal pancreas architecture. The presence of lymphocytes that have
infiltrated the pancreas are crucial mediators of β-cell destruction as this signifies chronic
inflammation of the pancreas (Cerf, 2013). According to De Loreto and Magbuhat (2016),
such alterations occur in the chronological manner of hypertrophy, necrosis, immune cell
infiltration, fibrosis, and hemorrhage. Thus, the manifestation of these abnormalities is
reflective of the individual’s state of diabetes (Robertson et al., 2003; Kawahito et al., 2009;
Wolff & Dean, 1987).
43
Likewise, reflective of an underlying pathology of the pancreas is the islet diameter.
In studies performed by Kilimnik and his associates (2012), when islet diameter of normal
and diabetic patients were compared, it was found that there was a preferential loss of large
islets (>60 µm in diameter) in diabetic patients. This is also corroborated by the study of
Rawal and her colleagues (2013), where islet diameter of diabetic patients were found to be
significantly smaller than islet diameter of nondiabetic patients. In this study, this was
substantiated with islet disruption in diabetic patients, resulting in a smaller diameter.
Group A: Negative Control (Standard Diet)
This group has been fed with a standard diet of mice pellets throughout the duration
of the study. No gross morphological abnormalities nor alterations in normal pancreas
histology have been observed. Both the Islets of Langerhans and the surrounding acinar cells
remained intact and free of abnormalities. Notably, this group exhibited the lowest
histological score of 0.2, which indicates no incidence of histological alterations or damages
in the pancreatic tissue. This group also exhibited a relatively high mean islet diameter,
ranking third among all groups, suggesting a healthy pancreas. These results are attributed to
standard conditions with which this group was subjected as well as the absence of
administration of HFD and STZ.
Group B: HFD + STZ + Metformin
This group has been administered with HFD and STZ, followed by a treatment of 40
mg/kg of Metformin. After gross morphological analysis, it was found that the pancreas was
whitish in color, lobular in shape, and exhibited black to red blotches, indicative of necrosis
and hemorrhage. These blotches were specifically observed with great abundance in the tail
region of the pancreas and minimally in the head region of the pancreas.
44
The tail region of the pancreas is the region closest to the spleen, an organ of the
lymphatic system. According to Debi and his colleagues (2013), this region is the most
susceptible to pancreatic injury. In relation to this, pancreatic injuries are rarely a solitary
event, and in majority of instances, multiple organ injuries occur. Notably, the spleen, a
secondary lymphoid organ nearest the tail of the pancreas, can contribute to pancreatic injury
(Kshirsagar et al., 2015). This contribution to pancreatic injury by the spleen can be
attributed to the vascular connections between the two organs. According to Ley and his
colleagues (2012), there is increasing evidence that the spleen harbors stem cells that act as
precursors to insulin-producing cells. In this case, β-cell precursors get delivered to the
pancreas through the splenic artery and its pancreatic branches which drain largely into the
tail region and minimally into the body of the pancreas. From this information, we can
deduce that most β-cell precursors initially reside in the tail region until they migrate in
different regions of the pancreas. Since STZ is a selective β-cell toxin, β-cell precursors
initially residing in the tail are also affected. Increase in circulation of β-cell precursors from
the spleen into the tail region of the pancreas occurs to compensate β-cell destruction in due
to STZ. This cycle of delivery and destroy of β-cells in the tail region explains the abundant
gross morphological aberrations observed (Debi et al., 2013; Kshirsagar et al., 2015).
White spots observed in the pancreas are a result of pancreatic enzymes which liquefy
fat cell membranes. These pancreatic enzymes are released in response to injury to the
pancreas, such as infection, toxins, viruses, trauma, or ischemia. The resulting fatty acids
from this enzymatic breakdown combine with calcium to form the grossly visible chalky
white nodules, which can later on develop into fat necrosis (Lack, 2003; Lombardi, Estes, &
Longnecker, 1975).
45
Histological abnormalities observed in this group include parenchymal necrosis,
steatosis, fibrosis, hemorrhage, and lymphocyte infiltration. Although metformin is used in
the treatment of hyperglycemic blood glucose levels, histological aberrations were still found
to be present. This can be attributed to the mechanism of proliferation of β-cells. Normally,
pancreatic β-cells have normal proliferative potential after a short quiescence period of
several days. However, this quiescence period is lengthened with age. Further analysis
suggests that replicated β-cells are less likely to divide again compared to unreplicated β-
cells, and that they enter a prolonged refractory period, estimated in months (Salpeter et al.,
2010; Teta et al., 2007). This idea corroborates the idea of a study by Desgraz and Herrera
(2009), suggesting that a single β-cell undergoes only two or three replications over the
course of its lifetime. Toxicity-induced and impaired β-cells at the time of HFD and STZ
administration might have remained in the pancreas of Group B, accounting for the
insignificant difference with that of Group F’s islet diameter.
Although several histological abnormalities were observed, this group was second to
Group A, in terms of the best histological score. However, in terms of islet diameter, it
ranked second to the lowest, and had an insignificant difference with that of Group F, the
group with the smallest islet diameter. Although there is a scale discrepancy, our findings
suggest that histological analysis is a more reliable parameter than islet diameter for analysis
of diabetes-induced aberrations. This is because some islets may indeed be large in size, but
this is actually due to the presence of hypertrophic cells. These instances are further
explained in the pancreatic histological analysis of Group C.
46
Group C: HFD + STZ + 10 mg/kg Xanthone Glycoside
The pancreas of Group C which was treated with 10 mg/kg of xanthone glycoside
exhibited multiple red to black blotches in their pancreas and as well as hemorrhage. These
blotches were particularly observed at the head and body of the pancreas. Occasionally, a few
fat deposits were found around and within the pancreas.
The head and uncinate regions of the pancreas are two of the most resistant regions of
pancreas when it comes superficial fat necrosis (Biffl, et al., 2013; Howard & Wagner,
1989). Within these locations, the main pancreatic duct and intrapancreatic ducts can be
found. In relation to this, a study by Butler and his colleagues (2010) indicated the
correlation between high fat diet and obesity with upregulation of pancreatic duct cell
replication. The increase in the rate of replication of pancreatic duct cells causes necrosis to
the excess cells due to the lack of oxygen coming from the blood vessels.
A portion of the body of the pancreas share the same the blood vessels of the tail
forming the corporocaudate segment (Busnardo, DiDio & Thomford, 1988). The body of the
pancreas also receives a portion of the β-cells progenitor stem cells from the splenic artery.
STZ is a toxin specific for β-cells and its precursors thus necrosis will likely occur in the area
where there are numerous β-cell stem cells. Presence of necrosis at body of the pancreas can
also be caused by a disruption of the main pancreatic ducts (Gmeinwieser, et al., 2000).
Pancreatic enzymes, when reacted with the fat deposits, causes superficial fat necrosis.
Histological abnormalities observed in this group are severe parenchymal necrosis,
fibrosis, mild steatosis, hemorrhage and lymphocyte infiltration. This group exhibited the
largest islet diameter out of the six groups. However, it was observed that the large size of
the islets was attributed to hypertrophic cells. In addition, the islets were severely damaged
47
with multiple necrotic cells and fibrosis. The histological index scores of Group C is the
lowest among the treatment groups. The acinar cells of this group are relatively normal with
minimal hemorrhage and hypertrophy of cells when compared to Group A (Negative
Control). The low scores given to the acinar cells may have contributed to the overall mean
histological score. Despite that, severe damages to the islets still suggest that 10 mg/kg of
xanthone glycoside is not the optimal dosage due to the lack of protective effects, such as
alleviating cell necrosis and atrophy, on the islet itself.
The mode of islet cell death in STZ-induced diabetes is necrosis. According to
Fehsel, Kolb-Bachofen and Kröncke (2003), in vitro treatment of pancreatic islets with high
concentrations of STZ showed evidence of necrosis. Under the electron microscope,
disrupted plasma membrane and spilled-out cellular constituents were evident in the
pancreatic islets. DNA damage in necrotic cells are caused by the activation of enzymes such
as intranuclear DNAse and poly(ADP-ribose) polymerase. In a study done by Leist and his
colleagues (1997), availability of ATP is a decisive factor on the mode of cell death. During
DNA damage in necrotic cells, the reduced frequency of base excision repair-induced strand
breaks and activation of poly(ADP-ribose) polymerase (PARP) causes the depletion of ATP.
ATP depletion leads to cell necrosis (Cardinal, et al., 2001).
The results suggest that this dose is not optimal because the given dose was not
enough or underdosed. An underdose of a drug or medication cause the treatment to be
ineffective. A study showed that a low dose of xanthone prevented the GLUT-4 expression in
diabetic mice (Ratwita, et al., 2017). As seen in the islets, several necrotic cells are still
evident on the β-cells thus this suggest that xanthone glycoside failed to induce its protective
effects on the islets.
48
Group D: HFD + STZ + 20 mg/kg Xanthone Glycoside
The pancreas found in Group D exhibited a pale white color and few black blotches
particularly observed at the head and body of the pancreas. Similar to Group C, the whitish
color of the pancreas can be attributed to the reaction of fats and pancreatic enzymes found at
the exocrine portion of the pancreas. Necrosis at the head and body portions of the pancreas
can be attributed to the damages and excessive cell proliferation at the main pancreatic ducts
(Gmeinwieser, et al., 2000; Butler, et al., 2010).
Mild parenchymal necrosis, severe fibrosis, steatosis, hemorrhage and lymphocyte
infiltration were the histological abnormalities found in this group. Its high histological score
can be attributed to the acinar damage and fibrosis found in the acinar portion of the
pancreas. However, islets of this group only show a few occurrences of necrotic cells, and its
islets are relatively bigger than Group A (Negative Control) and is significantly different
from Group F (Positive Control). This suggest the possibility that 20 mg/kg of xanthone
glycoside is the optimal dose.
Oxidative stress plays an important role in the development of diabetes. One such
metabolic complication involves the overproduction of mitochondrial superoxide in
endothelial cells of blood vessels. The increased production causes the activation of polyol
pathway flux, increased formation of advanced glycation end-products (AGEs), increased
expression of the receptor for AGEs and its activating ligands, activation of protein kinase C
(PKC) isoforms, and overactivity of the hexosamine pathway which are major complications
in diabetic patients (Giacco & Brownlee, 2010). Moreover, islets are susceptible to reactive
oxygen species (ROS)-induced damages because they exhibit low antioxidant activity. Major
antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione
49
peroxidase (GPx) are suppressed or inactive (Robertson, et al., 2003). Factors involving beta
cell dysfunction includes generation of ROS due to hyperglycemia and susceptibility of the
islet to oxidative stress. A study done by Benjamin and her colleagues (2013) reported that P.
pellucida increase antioxidant activities of the SOD and catalase to prevent accumulation of
ROS or free radicals. Prevention of free radical accumulation may lead to prevention of
oxidative stress of the pancreatic islets. In one study done by Hasnain and his co-workers
(2016), suppression of oxidative stress can revert a β-cell to its normal structure and function.
This suggest that P. pellucida has this property to alleviate ROS-related damages to the
pancreas.
P. pellucida also have anti-inflammatory components such as peperomin E (Xu, et al.,
2006). Low doses of STZ causes inflammation and lymphocyte infiltration in the β-cells of
the pancreatic islets which in turn decreases synthesis and secretion of insulin. P. pellucida
can combat the effects of inflammation thus preventing lymphocytes from infiltrating in.
High amounts of ROS associated with the production of inflammatory cytokines are involved
in the NF-κB pathway (Lawrence, 2009). Therefore, this suggests that P. pellucida prevents
necrosis, immune cell infiltration and inflammation by suppressing oxidative stress and
inhibition of the NF-κB pathway.
The xanthone family are also known to be powerful inhibitors of α-glucosidases. α-
Glucosidases are membrane-bound enzymes of the glycoside hydrolase family 31 which
function in hydrolyzing large carbohydrate molecules to glucose and other monosaccharides.
Inhibition of this enzymes delay the release of glucose thus delaying glucose absorption of
target cells. α-Glucosidase inhibitors are useful in treating diabetes and other prediabetic
conditions. Xanthones are also possible inhibitors of aldose reductase, an enzyme found in
50
the polyol pathway responsible for reducing glucose to sorbitol (Zheng, et al., 2014). In
diabetic patients, aldose reductase become more active and produces more sorbitol thus
activating the polyol pathway. This pathway is responsible for transforming glucose to
fructose, however it uses large amounts of NADPH and NAD. Reduced NADPH levels
prevents formation of glutathione which helps in reducing hydrogen peroxides to water.
Increased NADH levels allow high levels of oxidative stress which allows more diabetic
complications such as cardiovascular problems to happen (Tang, Martin and Hwa, 2012;
Nishimura, 1998). This suggest a possible antihyperglycemic function of the xanthone
glycoside found in P. pellucida.
Group E: HFD + STZ + 40 mg/kg Xanthone Glycoside
The gross morphology of the pancreas of Group E shows small black blotches,
observed at the body, tail, and uncinate process of the pancreas, which may indicate the
presence of necrotic cells or internal bleeding.
In particular, blotches were observed abundantly at the middle of the body and tail of
the pancreas. Based on reports by Debi et al. (2013), Kshirsagar et al. (2015), and Ley et al.
(2012), these blotches were brought about by the accumulation of β-cell precursors and their
apparent destruction by STZ in that area. Minimal blotches were observed at the uncinate
process of the pancreas. Blotches observed in this area are attributed to the conclusion of
Butler and his colleagues (2010) who indicated that following high fat diet administration,
there is upregulation of pancreatic duct cell regulation. This occurs over time and eventually,
as cells overcrowd in that region, cells at the center become deprived of their vascular
supply, causing necrosis.
51
The color which is white to pinkish also shows possible signs of
inflammation. Histological abnormalities observed in this group are parenchymal necrosis,
fibrosis, severe steatosis, severe hemorrhage and lymphocyte infiltration. From the islet
diameter, this group ranked fifth overall which signifies its relatively small diameter
compared to Group A and the other treatment groups. With high histological score, low islet
diameter, and presence of black blotches in the pancreas, the data suggest that 40 mg/kg may
not be the optimal dose of xanthone glycoside intake as it did not exhibit protective effects on
the pancreas of diabetic mice.
Many xanthone derivatives from other plants, such as 1,7-Dihydroxyxanthone and
Gartanin, have cytotoxic effects. Often times, cytotoxic drugs are used for cancer treatment.
Compounds with cytotoxic effects affect both healthy and cancerous tissues. Its mode of
action is disrupting the normal dividing cells thus effectively halting mitosis and proliferation
of cells. (Mazimba, et al., 2013). High amounts of compounds with cytotoxic effects may be
detrimental to the healthy cells of the subject. This may suggest the damage found on the
pancreatic cells are both inflicted by the xanthone compound and HFD/STZ. However,
xanthone glycosides found in P. pellucida are not fully studied yet in terms of its side effects.
Group F: Positive Control (HFD + STZ)
This group has been administered with HFD and STZ, with no treatment administered
afterwards. After gross morphological analysis, it was found that the pancreas was reddish in
color, lobular in shape, and exhibited black to red blotches observed at the tail region of the
pancreas.
The tail region of the pancreas, the region closest to the spleen is most susceptible to
pancreatic injury. This is because most β-cell precursors delivered by the spleen to the
52
pancreas initially reside in the tail region where they are destroyed by STZ, a potent β-cell
toxin. This cycle of delivery and destroy of β-cells in the tail region explains the abundant
gross morphological aberrations observed (Debi et al., 2013; Kshirsagar et al., 2015).
Histological abnormalities observed in this group include parenchymal necrosis,
steatosis, fibrosis, hemorrhage, and lymphocyte infiltration. This group had the third highest
histological score obtained. Notably, this group had the lowest islet diameter. This may be
attributed to the effect of STZ, a potent β-cell toxin, coupled with no administration of any
treatment or intervention afterwards.
53
CONCLUSION
This study demonstrated the effects of xanthone glycoside from Peperomia pellucida
on HFD/STZ induced diabetic mice through changes in body weights, blood glucose levels,
and evaluation of gross morphology, islet diameter and histopathological index scores of the
pancreas.
Treatment of xanthone glycoside for three weeks showed significant decrease in
blood glucose levels in groups administered with 20 mg/kg and significant increase in blood
glucose levels in groups administered with 40 mg/kg. This suggests that 20 mg/kg xanthone
glycoside is the optimal dose which can reduce hyperglycemia. This also suggests that at the
optimal dose, xanthone glycoside from P. pellucida can be an alternative to metformin in the
treatment of T2DM.
In terms of the histological effect of xanthone glycoside, it did not prevent
histological abnormalities from occurring. Surrounding acinar cells and islets still exhibited
abnormalities. However, when administered the optimal dose, islets were less affected and
even maintained a large diameter, like that of a normal and healthy pancreas.
54
RECOMMENDATIONS
Modification of the protocol, specifically by adjusting the treatment duration and
intervals, should allow ample time for β-cell recovery from STZ before introducing
treatments. Future diabetic studies should also look into the blood cholesterol levels of their
subjects, as these can further substantiate results obtained. It is also suggested that further
studies utilize the recommended dose of 20 mg/kg xanthone glycoside, and to test its effect
on other organs of the body, primarily the liver.
55
LITERATURE CITED
Abe, R., & Ohtani, K. (2013). An ethnobotanical study of medicinal plants and traditional
therapies. Journal of Ethnopharmacology, 145, 554-565.
Abeeleh, A., Bani Ismail, Z., Sami, A.-H., & Al-Essa, M. (2009). Induction of Diabetes
Mellitus in Rats Using Intraperitoneal Streptozotocin: A Comparison Between 2
Strains of Rats. European Journal of Scientific Research, 398-402.
Alberti, K., & Zimmet, P. (1998). Definition, diagnosis and classification of diabetes mellitus
and its complications part 1: diagnosis and classification of diabetes mellitus
provisional report of a WHO consultation. Diabetic Medicine, 15, 539-553.
American Diabetes Association. (2014). Diagnosis and classification of diabetes mellitus.
Diabetes Care, 37(1), S81-S90.
American Diabetes Association. (2017). Type 2 diabetes in children and adolescents.
Pediatrics, 105(3)
Aronoff, S.L., et al. (2004). Glucose metabolism and regulation: beyond insulin and
glucagon. Diabetes Spectrum, 17(3), 183-193.
Arrigoni-Blank, M., et al.(2004). Anti-inflammatory and analgesic activity of Peperomia
pellucida (L.) HBK (Piperaceae). Journal of Ethnopharmacology, 91(2-3), 215-218.
Bailey, J., Wilcock, C., & Scarpello, JH. (2008). Metformin and the intestine. Diabetologia,
51(8), 1552-1553.
Balandrin, M.F. (1996). Commercial utilization of plant-derived saponins: an overview of
medicinal, pharmaceutical, and industrial applications. Saponins Used in Traditional
and Modern Medicine, 1-14.
56
Balinado, L., & Chan, M. (2017). An ethnomedicinal study of plants and traditional health
care practices in District 7, Cavite, Philippines. International Conference on
Chemical, Agricultural, Biological and Medical Sciences, 23-24.
Beltran-Benjamin, K., et al. (2013). Enzyme activity and histopathology of rat liver treated
with crude methanolic extract of P. pellucida (L.) H.B.K. Journal of Biological
Sciences, 13(4), 183-195.
Biffl, W.L., et al. (2013). Western trauma association critical decisions in trauma:
management of pancreatic injuries. J Trauma Acute Care Surg., 75(6), 941-946.
Bo, T. & Liu, H. (2004). Separation methods for pharmacologically active xanthones.
Journal of Chromatography B, vol. 812 (1-2), 165–174.
Bowen, R. (2017). Gross and microscopic anatomy of the pancreas. Vivo pathophysiology, 1
Buettner, R., et al. (2006). Defining high-fat-diet rat models: metabolic and molecular effects
of different fat types. Journal of Molecular Endocrinology, 36, 485-501.
Busnardo, A.C., DiDio, L.J., & Thomford, N. R. (1988). Anatomicosurgical segments of the
human pancreas. Surg Radiol Anat., 10(1), 77-82.
Butler, A.E., et al. (2010). Pancreatic duct replication is increased with obesity and type 2
diabetes in humans. Diabetologia, 53(1), 21-26.
Byrne, F., Cheetham, S., Vickers, S., & Chapman, V. (2015). Characterization of pain
responses in the high fat diet/streptozotocin model of diabetes and the analgesic
effects of antidiabetic treatments. Journal of Diabetes Research, 1-13.
Cardinal, J.W., et al. (2001). Increased susceptibility to streptozotocin-induced β-cell
apoptosis and delayed autoimmune diabetes in alkylpurine- DNA-N-glycosylase-
deficient mice. Molecular and Cellular Biology, 21(16), 5605-5613.
57
Cerf, M.E. (2013). Beta cell dysfunction and insulin resistance. Front Endocrinology, 4, 37.
Cheng, J.T., et al. (2006). Novel mechanism for plasma glucose–lowering action of
metformin in streptozotocin-induced diabetic rats. Diabetes, 819-825.
Daughton, C., & Ruhoy, I. (2013). Lower-dose prescribing: minimizing “side effects” of
pharmaceuticals on society and the environment. Sci Total Environ, 443, 324-337.
Davidson, M., Ballinger, K., & Khetani, S. (2016). Long term exposure to abnormal glucose
levels alters drug metabolism pathways and insulin sensitivity in primary human
hepatocytes. Scientific Reports, 6, 28178.
da Silva, M., Zoghbi, M., Andrade, E., & Maia, J. (1999). The essential oil of Peperomia
pellucida Kunth and P. circinnata Link var. circinnata. Flavour and Fragrance
Journal, 14, 312-314.
Desgraz, R., & Herrera, P. (2009). Pancreatic neurogenin 3-expressing cells are unipotent
islet precursors. Development, 136, 3567-3574.
De Jager, J., et al. (2010). Long term treatment with metformin in patients with type 2
diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial.
BMJ, 20(340), c2181.
De Loreto, D. & Magbuhat, J.C. (2016). Protective effects of P. pellucida (L.) crude
methanolic extract against elevated blood glucose levels and alterations in pancreas
histology of HFD/STZ induced diabetic Mus musculus [Thesis]. Department of
Biology, University of the Philippines Manila.
Debi, U. et al. (2013). Pancreatic trauma: A concise review. World J Gastroenterol, 19(47):
9003-9011.
58
Defronzo, R., & Tripathy, J. (2009). Skeletal muscle insulin resistance is the primary defect
in type 2 diabetes. Diabetes Care, 32, S157-S163.
Deng, S. et. al. (2004). Structural and functional abnormalities in the islets isolated from
type 2 diabetic subjects. Diabetes, 53, 624–632.
Department of Health. (2007). Traditional and Alternative Medicine. Retrieved from
Department of Health: http://vrh.doh.gov.ph/index.php/en/health-guide#traditional-
alternative-medicine.
Dineshkumar, B., Mitra, M., & Manjunatha, M. (2010). Studies on the anti-diabetic and
hypolipidemic potentials of mangiferin (xanthone glucoside) in streptozotocin-
induced type 1 and type 2 diabetic model rats. International Journal of Advances in
Pharmaceutical Science, 1(1), 75-85.
Dolenšek, J., Rupnik, M., & Stožer, A. (2015). Structural similarities and differences
between the human and the mouse pancreas. Islets, 7(1).
Dy, A., & Olotu, M. (2016). Teratogenic and embryotoxic effects of methanolic crude extract
of P. pellucida (L.) Kunth on Danio rerio (Hamilton, 1822) Embryos [Thesis].
Department of Biology, University of the Philippines-Manila.
Ekor, M. (2014). The growing use of herbal medicines: issues relating to adverse reactions
and challenges in monitoring safety. Front Pharmacology. 4, 177.
Eleazu, C., et al. (2013). Review of the mechanism of cell death resulting from streptozotocin
challenge in experimental animals, its practical use and potential risk to humans. J
Diabetes Metab Disord, 12, 60.
59
Fehsel, K., Kolb-Bachofen, V. and Kröncke, K. (2003). Necrosis is the predominant type of
islet cell death during development of insulin-dependent diabetes mellitus in BB rats.
Laboratory Investigation, 83, 549–559.
Fitzgerald, E., Mathieu, S., & Ball, A. (2009). Metformin associated lactic acidosis. BMJ,
b3660.
Francois, T., et al. (2013). Composition and antifungal properties of essential oils from five
plants growing in the mountainous area of the West Cameroon. Journal of Essential
Oil Bearing Plants, 16, 679-688.
Garba, S. & Okeniyi, S.O. (2012). Antimicrobial activities of total alkaloids extracted from
some Nigerian medicinal plants. Journal of Microbiology, 4(3), 60-63.
Gbolade, A. (2009). Inventory of antidiabetic plants in selected districts of Lagos State,
Nigeria. Journal of Ethnopharmacology, 121, 135-139.
Geodakyan, S., et al. (1992). Experimental pharmacokinetics of biologically active plant
phenolic compounds. Phytotherapy Research 6, 332–334.
Giacco, F. & Brownlee, M. (2010). Oxidative stress and diabetic complications. Circulation
Research, 107(9), 1058–1070.
Gmeinwiesser, J., et al. (2000). Successful percutaneous treatment of infected necrosis of the
body of the pancreas associated with segmental disruption of the main pancreatic
duct. Gastrointestinal Endoscopy, 52(3), 413-415.
Gong, L., et al. (20112). Metformin pathways: pharmacokinetics and pharmacodynamics.
Pharamacogenet Genomics. 22(11), 820-827.
60
Graham, M., et al. (2011). The streptozotocin-induced diabetic nude mouse model:
differences between animals from different sources. Comparative Medicine, 61(4),
356-360.
Guha, S., Ghosal, S., & Chattopadhyay, U. (1996). Antitumor, immunomodulatory and anti-
HIV effect of mangiferin, a naturally occurring glucosyl-xanthone. Chemotherapy,
42, 443–451.
Guillermo, J. (2015). Pharmacognostic study and medicinal review of P. pellucida
(Ulasimang Bato). Biological Sciences Department, De La Salle University-
Dasmarinas, 2.
Hamzah, R., Odetola, A., Erukainure, O., & Oyagbemi, A. (2012). P. pellucida in diets
modulates hyperglyceamia, oxidative stress and dyslipidemia in diabetic rats. Journal
of Acute Disease, 1(2), 135-140.
Hasnain, S. Z., Prins, J. B., & McGuckin, M. A. (2016). Oxidative and endoplasmic
reticulum stress in b-cell dysfunction in diabetes. Journal of Molecular
Endocrinology, R33–R54.
Havsteen, B.H. (2002). The biochemistry and medical significance of the flavonoids.
Pharmacology & Therapeutics, 96, 67-202.
Heinrich, M. & Jäger, A. (2015). Ethnopharmacology in the Philippines.
Ethnopharmacology, John Wiley & Sons, 327.
Higuchi, M. (2010). Access to diabetes care and medicines in the Philippines. Asia-Pacific
Journal of Public Health, 22(3), 96S-102S.
Houtkooper, R. et al. (2011). The metabolic footprint of aging mice. Scientific Reports,
1, 134.
61
Howard, J.M. & Wagner, S.M. (1989). Pancreatography after recovery from massive
pancreatic necrosis. Annals of Surgery, 209(1), 31-35.
Hu, F., Lu, R., Huang, B., & Ming, L. (2004). Free radical scavenging activity of extracts
prepared from fresh leaves of selected Chinese. Fitoterapia, 14-23.
Ighodaro, O., & Akinloye, O. (2017). First line defense antioxidants-superoxide dismutase
(SOD), catalase (CAT), and glutathione peroxidase (GPX): their fundamental role in
the entire antioxidant defence grid. Alexandria Journal of Medicine, 9 (1).
Inman, K.S., Francis, A.A. & Murray, N.R. (2014). Complex role for the immune system in
initiation and progression of pancreatic cancer. World Journal of Gastroenterology,
20(32), 11160-11181.
International Diabetes Federation. (2015). International Diabetes Federation Atlas 7th
Edition. Retrieved from http://www.diabetesatlas.org/.
Jelodar, G., Mohsen, M., & Shahram, S. (2007). Effect of walnut leaf, coriander, and
pomegranate on blood glucose and histopathology of pancreas of alloxan induced
diabetic rats. Afr. J. Traditional, Complementary and Alternative Medicines, 4(3),
299-305.
Kawahito, S., et al. (2009). Problems associated with glucose toxicity: role of
hyperglycemia-induced oxidative stress. World Journal of Gastroenterology, 15(33),
4137-4142
Khan, A., Rahman, M., & Islam, S. (2008). Antipyretic activity of P. pellucida leaves in
rabbit. Turkish Journal of Biology, 32, 37-41.
Khan, A., Rahman, M., & Islam, M. (2010). Isolation and bioactivity of a xanthone glycoside
from P. pellucida. Life Sciences and Medicine Research, 2010, LSMR-1.
62
Kilimnik, G., et al. (2012). Quantification of islet size and architecture. Islets, 4(2):167-172.
Kim, D., et al. (2016). Beneficial effects of sarpogrelate and rosuvastatin in high fat
diet/streptozotocin-induced nephropathy in mice. PLOS ONE,
doi:10.1371/journal.pone.0153965.
Korou, L., et al. (2013). The effect of biological age on the metabolic responsiveness of mice
fed a high fat diet. Laboratory Animals Limited, 47(4) 241-244.
Kshirsagar, A. et al. (2015). Isolated pancreatic tail injury: a rare presentation. Ann Med
Sure (Long), 4(3), 230-232.
Kuwajima, H., et al. (1992). Phytochemistry. The International Journal of Plant
Biochemistry, 31(4), 1093-1450
Lack, E. (2003). Pathology of pancreas, gallbladder, extrahepatic biliary tract and ampullary
region. Oxford University Press, 0-19-513392-7.
Lawrence, T. (2009). The nuclear factor NF-kB pathway in inflammation. Perspect Biol,
1, a001651.
Lee, D., et al. (2017). Comparison of the response using ICR mice derived from different
sources to multiple low-dose streptozotocin-induced diabetes mellitus. Laboratory
Animal Research, 33(2), 150-156.
Lehmann, R., et al. (2007) Superiority of small islets in human islet transplantation.
Diabetes, 56(3): 594-603.
Leist, M., et al. (1997). Intracellular adenosine triphosphate (ATP) concentration: a switch in
the decision between apoptosis and necrosis. Journal of Experimental Medicine,
185(8), 1481-1486.
63
Ley, E. et al. (2012). Long-term effect of trauma splenectomy on blood glucose. J Sure Res,
177(1), 152-156.
Li, X. et. al. (2014). Hypoglycemic effect of catalpol on high-fat diet/streptozotocin-induced
diabetic mice by increasing skeletal muscle mitochondrial biogenesis. Acta Biochim
Biophys Sin, 46, 738-748.
Lin C., et al. (1984). The constituents of tripterospermum taiwanense Satake var. alpinum
Satake and pharmacological activity of some xanthone derivatives. Shoyakugaku
Zasshi, 38, 80–82.
Lin, Y., & Sun, Z. (2010). Current Views on Type 2 Diabetes. Journal of Endocrinology, 1-
11.
Lombardi, B., Estes, L., & Longnecker, D. (1975). Acute hemorrhagic pancreatitis (massive
necrosis) with fat necrosis induced in mice by DL-ethionine fed with a choline-
deficient diet. American Journal of Pathology, 465-480.
Longnecker, D. (2014). Anatomy and histology of the pancreas. Pancreapedia: Exocrine
Pancreas Knowledge Base, 1(12), doi: 10.3998/panc.2014.3
Marchetti, P., et al. (2004). Pancreatic islets from type 2 diabetic patients have functional
defects and increased apoptosis that are ameliorated by metformin. The Journal of
Clinical Endocrinology & Metabolism, 89(11), 5535-5541.
McCreight, L., et al. (2016). Metformin and the gastrointestinal tract. Diabetologia, 59, 426-
435
McCutcheon, J., Marinelli, M. (2009). Age matters. Eur J Neurosci, 29(5): 997-1014.
Mazimba, O., et al. (2013). Xanthones and anthranoids from the medicinal plants of Africa.
Medicinal Plant Research in Africa, 393-434.
64
Middleton, E., Kandaswami, C. & Theoharides, T.C. (2000). The effects of plant flavonoids
on mammalian cells: implications for inflammation, heart disease, and cancer.
Pharmacological Review, 52 (4), 673-751.
Muruganandan, S., et al. (2005). Effect of mangiferin on hyperglycemia and atherogenicity
in streptozotocin diabetic rats. Journal of Ethnopharmacology, 97, 497-501.
Mutee, A., et al. (2010). In vivo anti-inflammatory and in-vitro antioxidant activities of
P. pellucida. International Journal of Pharmacology, 6(5), 686-690.
Nakagawa, H. (2015). Recent advances in mouse models of obesity and nonalcoholic
steatohepatitis-associated hepatocarcinogenesis. World Journal of Hepatology, 7(17):
2110-2118.
Narayanamoorthi, V., Vasantha, K., Rency, R., & Maruthasalam, A. (2015). GC MS
determination of bioactive components of P. pellucida (L.) Kunth. Bioscience
Discovery, 6(2), 83-88.
Nasri, H. & Kopaei, M. (2014). Metformin: current knowledge. Journal of Research in
Medical Sciences, 19(7): 658-664.
National Diabetes Data Group. (1979). Classification and diagnosis of diabetes mellitus and
other categories of glucose intolerance. Diabetes, 28, 1039-1057.
Negi, J., et al. (2013). Naturally occurring xanthones: chemistry and biology. Journal of
Applied Chemistry 2013, 621459.
Nishimura, C. (1998). Aldose reductase in glucose toxicity: A potential target for the
prevention of diabetic complications. Pharmacological Reviews, 50(1), 21-34
65
Nurdiana, S., et al. (2017). Changes in pancreatic histology, insulin secretion and oxidative
status in diabetic rats following treatment with Ficus deltoidea and vitexin. BMC
Complementary and Alternative Medicine, 17, 290.
Pal, P., Sinha, K., & Sil, P. (2013). Mangiferin, a natural xanthone, protects murine liver in
Pb(II)-induced hepatic damage and cell death via MAP kinase, NF-kB and
mitochondria dependent pathways. Plos One, 8(2), e56894.
Park, K., & Lee, S. (2013). Anti-hyperlipidemic activity of Rhynchosia nulubilis seeds
pickled with brown rice vinegar in mice fed a high-fat diet. Nutrition Research and
Practice, 7(6), 453-459.
Peterson, J. (2014). Ten need-to-know facts about diabetes. American College of Sports
Medicine, 18(5).
Ragan, R. (2010). “Desarreglos propios del sexo”: Advertising Menstrual Disorders and
Regulating Women. Decimononica, 7(1), 40-60.
Rawal, S., et al. (2013). Effect of exercise on pancreatic islets in zucker diabetic fatty rats.
Journal of Diabetes and Metabolism, S10:007. doi:10.4172/2155-6156.S10-007
Ratwita, W. et al. (2017). Alpha mangostin and xanthone from mangosteen (Garcinia
mangostana l.) role on glucose tolerance and glucose transporter-4 in diabetes
mellitus. International Journal of Pharmacognosy and Phytochemical Research 9(9),
1206-1212.
Reeven, G. (1988). Role of insulin resistance in human disease. Diabetes, 37(12), 1595-1607.
Rice, S., et al. (2011). Action of metformin on the insulin-signalling pathway and glucose
transport in human granulosa cells. The Journal of Clinical Endocrinology and
Metabolism, 96(3), E427-E435.
66
Roberts, M. & Wink, M. (2013). Alkaloids: biochemistry, ecology, and medicinal
applications. Science, 6.
Robertson, R., et al. (2003). Glucose toxicity in beta-cells: type 2 diabetes, good radicals
gone bad, and the glutathione connection. Diabetes, 581-7.
Roslida, A., & Noor Aini, Z. (2009). Evaluation of gastroprotective effects of Peperomia
pellucida (L.) Kunth. Pharmacology Online, 2, 678-686.
Salpeter, S., et al. (2010). Risk of fatal and nonfatal lactic acidosis with metformin use in
type 2 diabetes mellitus. Cochrane, 14(4): 29
Saguibo, J. D., & Elegado, F. B. (2012). Resistance profile of probiotic lactic acid bacteria
against inhibitory effects of selected plant extracts. The Philippine Agricultural
Scientist, 95(1).
Savithramma, N., Linga Rao, M., & Ankanna, S. (2011). Screening of traditional medicinal
plants for secondary metabolites. International Journal of Research in
Pharmaceutical Sciences, 2(4), 643-647.
Scalbert, A. (1991). Antimicrobial properties of tannins. Phytochemistry, 30(12), 3875-3883.
Seifarth, C., Schehler, B., & Schneider, H.J. (2013). Effectiveness of metformin on weight
loss in non-diabetic individuals with obesity. Exp Clin Endocrinol Diabetes, 121, 27-
31.
Shagufta, W., & Irshad, A. (2016). Recent insight into the biological activities of synthetic
xanthone derivatives. European Journal of Medicinal Chemistry. doi:
10.1016/j.ejmech.2016.03.058.
Sio, S., Sia, I., & Cortes-Maramba, N. (2001). Antihyperuricemic effect of the freeze-dried
aqueous extract of P. pellucida (L) HBK (ulasimang bato) in rats. Acta Medica
67
Philippina, 37(1-2), 12-21.
Skovsø, S. (2014). Modeling type 2 diabetes in rats using high fat diet and streptozotocin.
Journal of Diabetes Investigation, 349–358.
Srinivasan, K., et al. (2005). Combination of high-fat diet-fed and low-dose streptozotocin-
treated rat: A model for type 2 diabetes and pharmacological screening.
Pharmacological Research, 213-220.
Stumvoll, M., Goldstein, B., van Haeften, T. (2005). Type 2 Diabetes: Principles of
pathogenesis and therapy. The Lancet 2005; 365:1333-1346.
Sultanbawa, M. (1979). Xanthonoids of tropical plants. Tetrahedron, 36: 1465-1506.
Ratwita, W. et al. (2017). Alpha mangostin and xanthone from mangosteen (Garcinia
mangostana L.) role on glucose tolerance and glucose transporter-4 in diabetes
mellitus. International Journal of Pharmacognosy and Phytochemical Research, 9(9),
1206-1212.
Tang, W.H., Martin, K.A., & Hwa, J. (2012). Aldose reductase, oxidative stress, and diabetic
mellitus. Frontiers in Pharmacology, 3, 87.
Teng, C., et al. (1989). Novel inhibitory actions on platelet thromboxane and inositol-
phosphate formation by xanthones and their glycosides. Biochemical Pharmacology,
38(21), 3791-3795.
Teta, L., et al. (2007). Growth and regeneration of adult beta cells do not involve specialized
progenitors. Dev Cell, 12(5): 817-826
Theresa-Ibibia, E. (2012). Phytochemical and antimicrobial analyses of extracts of
Peperomia pellucida (L). Journal of Pharmacy Research, 5(5), 2934-2937.
68
Viollet, B., et al. (2012). Cellular and molecular mechanisms of metformin: an overview.
Clinical Science, 122(6), 253-270.
Xu, S., Li, N., Ning, M., Zhou, C., Yang, Q., & Wang, M. (2006). Bioactive Compounds
from P. pellucida. Journal of Natural Products, 69, 247-250.
Wolff, S., & Dean, R. (1987). Glucose autoxidation and protein modification: the potential
role of autoxidative glycosylation in diabetes. Biochemistry Journal, 245: 243-250.
Wu, K., Huan, Y. (2008). Streptozotocin-Induced Diabetic Models in Mice and Rats. Wiley
Interscience, doi: 10.1002/0471141755.ph0547s40
Wei, L., Wee, W., Siong, J., & Syamsumir, D. (2011). Characterization of anticancer,
antimicrobial, antioxidant properties and chemical compositions of P. pellucida
leaf extract. Acta Med Iran, 49(10), 670-674.
Yang, Y. et al. (2014). Variations in body weight, food intake, and body composition after
long-term high-fat diet feeding in C57BL/6J mice. Obesity Silver Spring, 22(10):
2147-2155.
Yu, T., et al. (2017). Streptozotocin-treated high fat fed mice: A new type 2 diabetes model
used to study canagliflozin-induced alterations in lipids and lipoproteins. Hormone
and Metabolic Research, 49(5), 400-406.
Zheng, H., et al. (2014). Xanthones from Swertia mussotii as multitarget‐directed antidiabetic
agents. Chem Med Chem, 9(7), 1374-1377.
69
APPENDIX
Appendix A. Letter of Approval for Implementation from the IACUC, NIH
70
Appendix B. Authentication from Institute of Biology, College of Science, University of
the Philippines Diliman
71
Appendix C. Phytochemical Analysis Results of Butanol Fraction from Peperomia
pellucida from NIH, UP Manila
72
73
Appendix D. Computations for Total Xanthone Glycoside Needed
*Assumed weight of mouse is 30 g
0.3 mg XG x 5 mice x 21 days = 31.5 mg XG
0.6 mg XG x 5 mice x 21 days = 63 mg XG
1.2 mg XG x 5 mice x 21 days = 126 mg XG
Total XG: 220.5 mg XG
Appendix E. Computation for Streptozotocin Amount
*Assume the weights of the mice are around 20-30 g
0.8 mg STZ x 25 mice x 5 days = 100 mg STZ
1.2 mg STZ x 25 mice x 5 days = 150 mg STZ
TOTAL: 100-150 mg of STZ
Appendix F1. Paired T-Test Results Between Before and After HFD/STZ Induction
Body Weights (g)
Treatment
Group T-critical p-value Significance
A 2.776 0.017 SIGNIFICANT
B 3.182 0.012 SIGNIFICANT
C 2.776 0.004 SIGNIFICANT
D 2.776 0.006 SIGNIFICANT
E 2.776 0.009 SIGNIFICANT
F 3.182 0.035 SIGNIFICANT
74
Appendix F2. Paired T-Test Results Between Body Weights (g) of Mouse Subjects
Before and After Treatment
Treatment
Group T-critical p-value Significance
A 2.776 0.020 SIGNIFICANT
B 3.182 0.228 NOT SIGNIFICANT
C 2.776 0.432 NOT SIGNIFICANT
D 2.776 0.039 SIGNIFICANT
E 2.776 0.141 NOT SIGNIFICANT
F 3.182 0.006 SIGNIFICANT
Appendix G1. Paired T-Test Results Between Blood Glucose Levels (mg/dL) of Mouse
Subjects Before and After STZ Induction
Treatment
Group T-critical p-value Significance
A -1.520 0.102 NOT SIGNIFICANT
B -1.025 0.191 NOT SIGNIFICANT
C -1.956 0.061 NOT SIGNIFICANT
D -3.093 0.018 SIGNIFICANT
E -3.531 0.012 SIGNIFICANT
F -0.272 0.402 NOT SIGNIFICANT
Appendix G2. Paired T-Test Results Between Blood Glucose Levels (mg/dL) of Mouse
Subjects Before and After Treatment
Treatment Group T-critical p-value Significance
A -0.701 0.261 NOT SIGNIFICANT
B -0.839 0.232 NOT SIGNIFICANT
C -1.053 0.176 NOT SIGNIFICANT
D 2.937 0.022 SIGNIFICANT
E -3.518 0.012 SIGNIFICANT
F -1.503 0.115 NOT SIGNIFICANT
75
Appendix H1. Kruskal-Wallis One-way ANOVA Results for Mean Histological Index
Scores
Appendix H2. Mann-Whitney U Test Results for Mean Histological Index Scores
Treatment
Group
Mann-
Whitney U
Wilcoxon
W Z
Asymp. Sig.
(2-tailed)
Exact
Sig. Significance
A B 0.000 21.000 -3.108 0.002 0.002 SIGNIFICANT
C 0.000 21.000 -3.108 0.002 0.002 SIGNIFICANT
D 0.000 21.000 -3.102 0.002 0.002 SIGNIFICANT
E 0.000 21.000 -3.089 0.002 0.002 SIGNIFICANT
F 0.000 21.000 -3.089 0.002 0.002 SIGNIFICANT
B
C 15.500 36.500 -0.436 0.663 0.699
NOT
SIGNIFICANT
D 16.500 37.500 -0.258 0.796 0.818
NOT
SIGNIFICANT
E 11.000 32.000 -1.185 0.236 0.310
NOT
SIGNIFICANT
F 13.000 34.000 -0.846 0.397 0.485
NOT
SIGNIFICANT
C
D
17.500 38.500 -0.086 0.931 0.937 NOT
SIGNIFICANT
76
E 14.000 35.000 -0.677 0.498 0.589
NOT
SIGNIFICANT
F 16.000 37.000 -0.339 0.735 0.818
NOT
SIGNIFICANT
D E 0.000 10.000 -2.530 0.011 0.029 SIGNIFICANT
F 0.000 10.000 -2.381 0.017 0.029 SIGNIFICANT
E F 7.500 17.500 -0.643 0.521 0.556
NOT
SIGNIFICANT
Recommended